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1. INTRODUCTION 
  Diabetes mellitus is a major lifestyle disorder, which is a problem faced 
majorly by the world today. WHO defines Diabetes mellitus as a metabolic disorder 
of multiple aetiology characterized by chronic hyperglycemia with disturbances of 
carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, 
insulin action, or both. It is characterized by the symptoms such as thirst, polyuria, 
blurring of vision and weight loss. 
According to International Diabetes Federation (IDF) Report 2015, 
 Worldwide - 450 million people have Diabetes and 318 million in pre-diabetic 
stage.  
 India is in the second spot with 69.2 million people with Diabetes. India leads 
the word with largest number diabetics earning the name “Diabetes capital of 
the world”[1] 
According to the latest reports from WHO, it is estimated that 415 million people 
suffered with Diabetes globally in 2015. In the year 2012 to 2015, an estimated 1.5 to 
5.0 million deaths were caused by diabetes. WHO projects that diabetes will be the 7
th
 
leading cause of death in 2030 
[2]
.  
In 2014, India topped the world with the highest number of people with diabetes 
mellitus. It is predicted that by 2030, diabetes mellitus may affect up to 79.4 million 
individuals in India.
[3]  
 The mortality rate was estimated 24 million persons with in India in 2000 and this 
number is predicted to rise to almost 70 million people by 2025
[4]
.
 
Current treatment strategy for Diabetes mellitus includes conventional therapy 
with Insulin in case of Type-1 Diabetes and with wider combination of drugs in case 
of Type-2 Diabetes mellitus. Some of the commonly used drugs are Meglitinides, 
Sulfonylurea and Biguanides. 
   Meglitinides – a class of drug that act by promoting insulin secretion from 
pancreas. Among these  Repaglinide(Prandin)  and Nateglinide(Starlix) is particularly 
beneficial in lowering blood glucose after meals and does not tend to lower fasting 
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glucose levels  to the same degree.  The possible side effects of these drugs include 
sweating, confusion, tremors and coma. 
Sulfonylurea drugs include glyburide (Diabeta), glipizide (Glucotrol) and 
glimepiride (Amaryl) – rapidly lower blood sugar, but can cause hypoglycemia. These 
drugs are to be avoided in patients with Sulfa allergy. 
  Metformin – has the ability to decrease glucose production by the liver. The 
possible side effects are loss of appetite and renal impairment 
[5]
.  
In Siddha system Diabetes mellitus is referred as Madhumegam. Medical 
experts in Siddha medicine with exposure to modern science correlate Madhumegam 
to Diabetes mellitus. This is mainly because of the etymology that mellitus means 
sweetness which is madhu. The word „Madhu‟ means honey, the word „Megam‟ in 
the Siddha system is releated to urinary disorder. Hence passing urine with sweetness 
is called „Madhumegam‟. The name Madhumegam is suitable for the symptoms of 
passing urine with sweetness. Extensive details of the urinary diseases which manifest 
as excessive urination or decreased urination is explained by Siddhar Therayar, one of 
the pioneers of the Siddha medical system, as Neerinai perukkal noi and Nerinai 
arukkal noi. Madhumegam is classified under “Neerinai perrukkal noi” 
It is quoted as, 
ePupUtpidf; Fzj;ij ePawptpupj;J nrhy;thk; 
ePhpidg; ngUf;fnyhd;W ePupidaUf;f nyhd;W 
ePupopTlNd nfhy;Yk; ePh;f;fl;L tpidfnsd;W 
ePzpyKiwf; Fkpe;j ePh;epiwf; Fzj;ijf; Nfsha; 
-                         Njiuah; kfhfupry;[6] 
The sudden spurt in life style modification, ethical susceptibility and vast 
urbanization has made India the Diabetic capital of the World. 
   Siddhars have explained the 10 stages of Madhumegam called Avathai and 
also the symptoms in each stage by mentioning about medicines for Madhumegam , 
they have prescribed both herbal and mineral preparations. 
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The Siddha system of medicine has been in practice in our country since time 
unknown. The Siddha system of medicine is one of the ancient system of medicine. 
This system is having a specific character and having speciality that it not only cures 
the disease but also prevents the disease. This system of medicine is a complex of 
spirituality and healing technology that exploits herbal, metal, mineral substance, 
standing of course on tested theoretical foundations. 
Siddhars were a disparate band of poet – philosophers with wide range of 
interests and capabilities.  Their compositions are replete with philosophies of life 
which are unorthodox and radical in nature.  Nevertheless, they are essentially men of 
medicine, and their philosophy is the philosophy of medicine.  Their compositions 
comprised profound insights into securing the health of human body and mind as 
well.  Their knowledge of the medical uses of a whole parts of herbs, metals and 
minerals is indeed so comprehensive and eclectic are their conceptions of medicine 
that they should not only make for a rewarding complement to all Synthetic drugs,  
but give a new perspective to our philosophy of healing.
[7] 
The Siddha system of medicine insists the use herbals first which is quoted as 
“Nth; ghU jio ghU kpQ;rpdf;fhy; 
 nky;y nky;y gw;g nre;J}uk; ghNu” 
- fz;Zrhkpak; gps;is  
This system has 64 different types of medications which includes internal as 
well as external medications. Urundai (pills) is one among the internal medicines. 
Siddha system offers cure for several diseases and also in the management of various 
incurable diseases. One such disease is Diabetes mellitus.  
Elathy urundai is a poly herbal formulation comes under the classification of 
internal medicine is mentioned as a potent anti-diabetic drug in the Siddha classical 
literature Sarabendrar Vaidhiya Muraigal indicated for Diabetes. Till now no 
scientific research works have been carried out on this poly herbal formulation, the 
author is interested in validating the efficacy of Elathy urundai as a potent anti-
diabetic drug through physico chemical analysis, phytochemical analysis, biochemical 
analysis, pharmacological studies. 
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In Siddha system, Kaya Kalpa  medicines which can revive the beta cells 
secreting insulin have been explained. This is a metabolic disorder, hence Kaya Kalpa 
medicines which can revive the ruined beta cells have been prescribed by the Siddhars 
long ago. 
 
Universal blue circle symbol for diabetes 
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2. AIM AND OBJECTIVES 
Aim 
 Diabetes mellitus is a metabolic disorder and now it is a lifestyle disorder 
which is a great threat to the mankind. As there is a great change in our day to day 
activities, food habits, physical activities etc., this disease has got its own spurt 
worldwide. Particularly India is the leading one as it is getting more westernized. This 
disease needs a prolonged treatment with safe medication and quality living. This 
could be achieved by Siddha system of medicine as it not only treats the disease but 
also brings the overall wellbeing of  human. 
 According to the Siddha literature Elathy Urundai was used for Diabetes 
mellitus. Thus the aim of this study was to validate the safety and efficacy of the test 
drug Elathy Urundai for Anti-Diabetic Activity in Streptozotocin induced Wistar 
albino rats. 
Objectives 
The following methodology was adopted to evaluate the safety and efficacy of the 
test drug in this study 
 Collection of various Siddha and modern literature relevant to the study. 
 Preparation of the drug according to the classical Siddha literature. 
 Physicochemical and phytochemical investigation of the test drug. 
 Evaluate bio-chemical analysis of the test drug to derive acidic and basic 
radicals. 
 To estimate the percent of elements, functional groups and particle size through 
instrumental analysis of the trial drug. 
 Evaluation of the Acute and 28 days repeated dose Toxicity of test drug 
according to OECD guidelines. 
 Evaluation of pharmacological study of the drug through the following 
activities 
 Anti-Diabetic Activity-Streptozotocin induced diabetes in Wistar albino 
rats. 
 Anti-Dyslipidemic Activity-Triton WR 1339 induced Dyslipidemic in 
Wistar albino rats. 
 Anti-Oxidant Activity-Through DPPH assay  
 To scrutinize all the above studies to establish the potency of Elathy Urundai. 
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                               3. REVIEW OF LITERATURE 
3.1. DRUG REVIEW 
3.1.1. GUNAPADAM  ASPECT 
Ingredients of Elathy Urundai 
 Elam (Elettaria cardamomum) 
 Kirambu (Syzygium aromaticum) 
 Ilavanga pathiri (Cinnamomum tamala) 
 Aavarai panchangam (Cassia auriculata) 
 Seenthir kizhangu (Tinospora cardifolia) 
 Thannervittan kizhangu (Asparagus recemosus) 
 Thamarai valaiyam (Nelumbo nucifera) 
 Butter Milk        
1.Elam
[8A]
: 
Alternative names: Aanje, Korangam, Thudi 
Vernacular names:  
Malayalam :   Elattari 
Sanskrit :   Ela 
Kan  :   Elakki 
Properties: 
 Suvai (Taste)         :  Kaarppu  
 Thanmai (Nature)  :  Veppam 
 Pirivu (Division)    :   Kaarppu 
Actions :    
 Stomachic 
 Carminative 
 Stimulant 
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General character: 
                    “njhz;il tha;fTs; jhYF jq;fspy; 
               Njhd;Wk; Nehajp rhuk;gd; Nkfj;jhy; 
          cz;il Nghy;vOq; fl;b fpupr;ruk; 
               coiy the;jp rpye;jp tp\Q;Ruk; 
          gz;il ntf;if tpjhfNeha; fhrKk;  
               ghOqQ; Nrhkg; gpzptpe;J el;lKk; 
          mz;il aPistd; gpj;jk; ,itf;nfy;yhk; 
               My khq;fko; Vy kUe;jNj… 
                                   - Njud; Fzthflk; 
It is used in the treatment of mouth and palate disorders, cough, diarrhea, 
poisonous stings of insect bites and increases the sperm count.      
2. Kirambu
[8B]
: 
Alternative names: Anjukam, Urkadam, Karuvai kirambu, Sossam, Therali, 
Varangam 
Vernacular names: 
Malayalam:    Kirampu 
 Sanskrit   :    Lavanga 
 Kan   :    Lavanga 
Properties 
 Suvai (Taste)   : Kaaram 
 Thanmai (Nature) : Veppam 
 Pirivu (Division)  :Kaarppu 
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Action: 
 Stimulant  
 Carminative 
 Stomachic 
General characters:  
“gpj;j kaf;fk; NgjpnahL the;jpAk;Nghk; 
 Rj;jtpuj; jf;fLg;Ge; Njhd;WNkh-nkj;j 
 ,ytq;fq; nfhz;ltUf; Nfw; RfkhFk; 
 kykq;Nf fl;Lnkd tho;j;J. 
 Rf;fpyel; lq;fHz #Htpaq;f yhQ;rde;jhl; 
 rpf;fy;tplhr; rHth rpag;gpzpA-kf;fpf;Fl; 
 lq;fg; G+NthL jupglUe; Njhd;wpypy; 
 tq;fg;G+ NthLiuj;J th. 
- mfj;jpaH Fzthflk; 
It is used in the treatment of giddiness, vomiting, dysentery, chronic diarrhea, 
ear diseases, scabies and eye diseases.           
3. Ilavanga pathiri
[8C]
: 
Alternative names          : Thalisapattiri, Thamalapattiri 
 Vernacular names    
Malayalam           - Paccila 
 Sans                    - Tamalapatram 
kan                      - Kadu lavanga patte 
Properties: 
Suvai (taste)   - Kaarpu 
Thanamai (nature) - Veppam 
 Pirivu (division)  - Kaarpu 
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Actions:   
 Stimulant 
 Carminative 
 Stomachic 
 Diaphoretic 
General characters: 
“NkfRuk; rPjRuk; ntl;ilRth rq;fhrk; 
jhfgpj;jk; the;jprH thrpaNeha; -Nkfj;jpd; 
fl;bNahL jhJel;lq; ifg;gUrp Nghf;fptpLk; 
,l;l,y tq;fj; jpiy”. 
- mfj;jpaH Fzthflk; 
Uses 
It is used in the treatment of fever, asthma, cough, thirst, vomiting, mouth 
ulcers, abscess, oligospermia and helps in modulating the bitter taste.  
4. Aavarai panchangam
[8D] 
Alternative names: Aavari, Aaverai, Eamaputpi, Makare, Aaguli, Thalapodam 
Vernacular names: 
Malayalam    :    Avara 
                Sans              :   Telapotakam 
Kan               :    Tangadi-gida,Avare-gida 
Properties:  
Suvai (Taste)           :  Thuvarppu 
Thanmai (Nature)   :  Thatpam 
Pirivu (division)       :  Inipu 
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Action: 
 Astringent 
 Tonic 
 Refrigerant 
 Alterative 
General characters: 
“Nkhfj;jp dhNy tpise;jryk; ntl;ilady; 
Mfj;jpd; Gz;Nzh lUq;fpuhzp-Nghfj;jhd; 
Mthiug; gQ;rfq;nfhs; mj;jpRuk; jhfKk;Nghk; 
Vthiuf; fz;klkh Nj” 
- mfj;jpaH Fzthflk;. ; 
It is used in the treatment of diabetes, leucorrhea, body heat, ulcers, amoebic 
dysentery, fever and thirst. 
5. Seenthir kizhangu
[8E] 
Other names: Amirthavalli, Somavalli, Amirthai, Amirthakodi, Gundali 
Vernacular name: 
Malayalam : Amrutha 
Sans              : Guduchi 
Kan                : Amruta-valli 
Properties 
 Suvai (Taste)        : Kaippu  
Thanmai (Nature) : Veppam 
 Pirivu (Division) : Kaarppu 
 
                                                                                        REVIEW OF LITERATURE 
 
ANTI DIABETIC ACTIVITY OF ELATHY URUNDAI  Page 11 
 
Actions: 
 Alterative 
 Antiperiodic 
 Aphrodisiac 
 Demulcent 
 Stimulant 
 Stomachic 
General character: 
“rPe;jpw; fpoq;fUe;jj; jPgdkhk; Nkftif 
Nghe;jTjp ug;gpj;jk; nghq;FRu-khe;jk; 
mjprhuk; nta;afzk; Mk;gyNeh NahNl 
fjptplKq; nfl;LtpLq; fhz;” 
- mfj;jpaH Fzthflk; 
It is used in the treatment of diabetes, hypertension, fever, dysentery, 
tuberculosis, cures poisonous bites and increases appetite. 
6. Thannervittan kizhangu
[8F]
: 
Other names: Thaneervittan, Sathaveli, Sathavari, Sathamoolam, Sathavari, 
Neervali, Narayani, Neervitan, Aagerugam, Varivari, Uthagamoolam, Seekuvai, 
Paranai, Peruthanthi.                      
Vernacular name: 
Malayalam  : Sataveri 
Sans   : Shatavari 
kan     : Satmula 
Properties: 
Suvai (taste)           :  Inippu 
Thanamai (nature) :  Thatpam 
Pirivu (division)      :  Inippu 
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Actions: 
 Nutritive 
 Demulcent 
 Galactagogue 
 Aphrodisiac 
 Antispasmodic 
General character   :  
“ePupopitg; Nghf;Fk; neLehl;R uj;ijnayhk; 
CiutpLj; NjhlT iuf;Fq;fhz;-ehupaNu! M 
ntz;zPHnga; NrhkNeha; ntl;il ady;jzpf;Fe; 
jz;zPHtpl; lhd;fpoq;F jhd;” 
        - mfj;jpaH Fzthflk; 
It is used in the treatment of diabetes, chronic fever, osteomyelitis, intense 
body heat. 
7. Thamarai valaiyam
[8G]
: 
Alternative names: Aravindham, Ellimanai, Suriya natpu, Ponmanai, Vindham, 
Pundareegam, Padhumam, Kamalam, Nalinam, Mundagam, Amberugam, Salasam, 
Pangerugam. 
Vernacular name: 
Malayalam :  Aravindam 
Sans    :  Pankaja 
kan    :  Tavare 
Properties: 
Suvai (taste)          :  Kaarpu 
Thanamai (nature) :  Veppam 
Pirivu (division)  :  Kaarpu 
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Actions: 
 Stimulant 
 Carminative 
 Stomachic 
 Diaphoretic 
General character   : 
“gUj;jew; whkiug;g+ gy;the;jp Nehiaj; 
Juj;jptpLk; ,d;DQ; nrhy;Nth- fuj;jpy; 
vLj;jizf;ff; fz;FspUk; VFQ; RuKk; 
vLj;jtp jhfKk;Nghk; vz;” 
-     mfj;jpaH Fzthflk; 
It is used in the treatment of eye irritation, fever, thirst. 
8. Butter milk
[9]
: 
“tPf;f kNfhjuKs; tPWFd;kk; ghz;Lgpj;je; 
jhf;FkUe; jpl;ljjp rhunkhL-$f;FuNy  
khwhj; jphpNjh\ ke;jkdw;; whfk;;Nghk; 
tPwhtpd; NkhUf;F nka;” 
- gjhh;j;jFz rpe;jhkzp. 
 
 
 
 
It is used in the treatment of swelling, ascites, stomach ache, anaemia, 
diarrhea, balances tridhoshas, cures indigestion and thirst.    
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3.1.2.  BOTANICAL ASPECT 
1. Elettaria cardamomum
[10A]
 
Taxonomical Classification 
 Kingdom  :  Plantae 
 Class   :  Monocotyledons 
Serious  :  Epigynaes 
Family  :  Zingiberaceae 
Genus  :  Elettaria  
Species :  cardamomum 
Distribution :  Cultivated throughout India. 
Description    :  Tall herbaceous perennial with branching stock, 1.5-5 m in height, 
Parts used      : Seeds   
Chemical constituents: 
                   Moton seeds contains trace waxes, alpha-terpinylacetate, cineole, linalyl 
acetate, limonene and linalool, limonene, cineole terpinolene, myrcene.
[11]
 
Properties and uses:  
               The seeds are aromatic, acrid, cooling, stimulant, carminative, digestive, 
stomachic, diuretic, cardio tonic. It is used in treatment of asthma, bronchitis, cardiac 
disorders, burning sensation, hyperdipsia. 
2. Syzygium aromaticum
[12A]
:                        
Classification 
Kingdom       :     Plantae 
Class              :     Dicotylendons 
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Order             :     Myrtales 
Family           :     Myrtaceae  
Genus            :     Syzygium 
Species            :     aromaticum 
Distribution     :    Cultivated in south India. 
Description      :   A pyramidal evergreen tree usually up to 12m in height with a single 
main stem bearing oblique branches. Leaves simple. Flowers are 
highly aromatic. 
Parts used      :    Dried flower buds. 
Chemical constituents: The main constituents of the essential oil are 
phenylpropanoids such as carvacrol,thymol,eugenol and cinnamaldehyde.
[13] 
Properties and uses: 
         The cloves are acrid, bitter, aromatic, refrigerant, carminative, stomachic, anti-
spasmodic, emollient, anthelmintic, sialagogue, rejuvenating. It is used in the 
treatment of anorexia, cough, burning sensation, skin diseases, helminthiasis, impurity 
of breast milk, neuralgia, dental carries and tuberculosis.  
3. Cinnamomum  tamala
[10B] 
Classification      
 Kingdom        :  Plantae 
Class                    :  Dicotyledons 
Order                    :  Laurales 
Family                  :  Lauraceae 
Genus                   :  Cinnamomum  
Species                 :  tamala 
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Distribution          : Distributed around Himalayas, in areas of 900-2400m 
elevation 
Description       :   A moderate sized evergreen tree 7.5m in height with dark 
brown or blackish rough bark. Leaves are simple opposite, alternate. Flowers pale 
yellowish in axillary and terminal.  
Part used           : Leaves 
Chemical constituents: 
     Cinnacassiol A, B and C, trans-cinnamic acid,cinnamaldehyde and eugenol
[14]
.
 
Properties and uses:     
       The leaves are bitter, sweet, aromatic, thermogenic, anthelmintic, diuretic, 
stimulant, carminative and tonic. 
4. Cassia auriculata
[10C]
  
Classification 
Kingdom    :    Plantae 
Class     :   Dicotylendons 
Order                 :   Rosales 
Family               :  Casesalpiniaceae 
Genus                :  Cassia 
Species              :  auriculata 
Distribution       : Throughout central and south India. 
Description        : A much branched shrub with reddish brown braches, leaves 
with subulate glands, cordate stipules at their bases. Flowers are bright yellow in sub-
terminal axillary corymbs. 
Parts used: Root, bark, leaves, flowers, seeds. 
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Chemical constituents: 
Flowers –β-Sitosterol And Kaempferol. 
Leaves - β-Sitosterol And Emodin. 
Pod Husk -β-Sitosterol, Chrysophanol, Emodin, Ruβicidin and Nonacosan-6-
One
 [15]
. 
Properties and uses:  
        Astringent, alterative, anthelmintic, aphrodisiac and stomachic. It is used in the 
treatment of diabetes, skin diseases, leprosy, ulcers, tumors, asthma, chyluria, chronic 
purulent conjunctivitis. 
5. Tinospora cordifolia
[12b] 
Classification 
Kingdom  :   Plantae 
Class               :  Dicotylendons 
Order                   :  Ranales 
Family                 :  Menispermaceae 
Genus                  :  Tinospora 
Species                :  cordifolia 
Distribution         : Throughout India in forests. 
Description           
 A large extensively spreading glabrous, perennial deciduous twinner with 
succulent stem and papery bark. Leaves are simple, alternate. Fruits are drupe, red 
when ripe. 
Parts used: Stem 
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Chemical constituents: 
Tinosporine, Tinosporon, Tinosporic Acid, Tinosporol, Tinosporide, 
Tinosporidine, Columbin, Palmar, Berberine, Giloin, B-Sitosterol, Cordifolide, 
Unosporin, Cordifol, Cordifolon
[16]
. 
Properties and uses: 
       Astringent, anti-periodic, anti-spasmodic, anti-inflammatory, anti-emetic, 
carminative, aphrodisiac, rejuvenating. It is used in the treatment of hyperdipsia, 
helminthiasis, dyspepsia, chronic fever, inflammation, gout, vomiting, skin disease, 
leprosy, anemia. 
6. Asparagus racemosus
[17]
:  
Classification:  
Kingdom  :   Plant kingdom 
Class                    :   Dicotyledons 
Order                   :   Coronarieae 
Family                 :    Liliaceae  
Genus                  :   Asparagus 
Species                 :   racemosus   
Distribution          :   Cultivated throughout India at an elevation upto 1300m. 
Description:              
  An armed, climbing undershrub with woody stem, young stems very delicate, 
brittle and smooth, and leaves reduced to minute chaffy scales and spines cladodes 
triquetrous. Flowers are white; the tuberous succulent roots are 30 cm to a meter or 
more in length, fascicled at the stem base, smooth, tapering at both ends. 
Parts used:    Tuberous roots 
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Chemical constituents: 
 4-Saponins - Shatavarin I, II, III, IV
[18] 
 Shatavarin IV is a Glycoside Of Sarsapogenin With 2 Moles Of Rhamnose And 1 
Mol of Glucose
 [19]
. 
 Flowers And Fruits - Glucosides Of Quercetin, Eutin,Hyperoside. 
Properties and uses:  
Emollient, nervine tonic, galactogogue, anodyne, aphrodisiac, diuretic, 
rejuvenating.  
It is used to treat nervous disorder, dyspepsia, diarrhea, gonorrhea, leucorrhea, 
hyperdipsia, burning sensation. 
7. Nelumbo nucifera
[20]
: 
Classification: 
Kingdom  :  Plantae 
Class   :  Dicotyledons 
Order   :  Ranales 
Family   :  Nymphaeaceae 
Genus   :  Nelumbo 
Species  :  nucifera 
Distribution : Throughout India in marshes and ponds, upto an elevation of              
1,800 m. 
Description  
Large handsome aquatic herb with slendar, enlongate branched creeping, 
rhizomes, sending out roots at the nodes.  
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Leaves  are peltate, 60-90 cm or more in diameter, petioles very long, smooth 
or with small or rosy with a centrally located yellow obconical spongy torus in which 
carpels are sunken, fruits ovoid, nut- like achenes. 
Parts used : Whole plant 
Chemical constituents:  
Megastigmane,nelumnucifoside A and new eudesmane sesquiterpene,eight 
alkanoids and eleven flavoinoids
[21]
  
Properties and uses: 
Astringent, emollient, diuretic, antipyretic, cardio tonic, anthelmintic. It is 
used to treat nervous exhaustions, skin diseases, pectoralgia, spermatorrhea, 
leucoderma, leprosy, haemorrhoids, cholera, fever, hepatopathy.  
3.2. REVIEW OF THE DISEASE 
3.2.1. Siddha aspect of the disease 
Madhumegam 
Madhumegam comes under Neerinai Perukkal Noi as mentioned in Therayar Maha 
Karisal. 
ePupUtpidf; Fzj;ij ePawptpupj;J nrhy;thk; 
ePhpidg; ngUf;fnyhd;W ePupidaUf;f nyhd;W 
ePupopTlNd nfhy;Yk; ePh;f;fl;L tpidfnsd;W 
ePzpyKiwf; Fkpe;j ePh;epiwf; Fzj;ijf; Nfsha; 
-                         Njiuah; kfhfupry; 
Synonym 
Mega neer, Vegu moothiram, Innipu neer, Neerizhivu, Thithippu neer, 
Pramegham. 
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Definition
[22] 
Madhumegam is a clinical condition characterized by frequent urination 
resulting in deterioration and diminution of the seven thathus and loss of weight.
 
 
Abdomen distention, slurring of speech, peripheral neuritis, lassitude, 
dyspnoea are the symptoms of Madhumegam. 
Etiology 
 Diet habits 
 Sexual indulgence 
 obesity 
 Psychosomatic cause 
 Hereditary 
 Excess stimulation of moolatharam 
General symptoms
 
 
 1. Thirst                                       
 2. Polydipsia                                
 3. Anorexia                                  
 4. Delirium                                   
 5. Sleeplessness                            
 6. Hiccough                                  
 7. Anaemia                                   
 8. Polyuria 
 9. Cough 
 10. Dyspnea 
 11. Pain in the hip and burning sensation 
 12. Loss of Weight 
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Classification of the disease 
Classification of Megam
[23] 
             Vali - 4                    Iyam - 10 
1. Neimananeer                                           1.Iyaneer               
2. Pasumananeer                                           2.Thuimaineer 
3. Seezhmananeer                                         3.Moolaineer  
4. Sadhaimananeer                   4.Ilaneer 
Azhal - 6                                                         5.Ulneer             
1. Yanaikozhupu Mananeer                               6.Thavalaneer 
2. Katrazhai Mananeer                                      7.Kazhuneer 
3. Chunna Mananeer                                        8.Thenneer 
4. Ennipu Megam                                             9.Uppuneer 
5. Palingu Neer                                                10.Kavichuneer 
6. Muyal Kuruthi Neer 
Diabetes mellitus is a clinical entity in a modern medicine is closely resembles 
one of the types of “Pitha Premeham” i.e “Madhumegam”. 
Clinical features 
Polyuria, polyphagia, polydipsia, perspiration, exhaustion, insomnia, giddiness 
and loss of weight even at normal consumption of food. 
Pathophysiology
 [24]
 
       In the disease Madhumegam, due to internal and external causes affect balance in 
the ratio of Vali, Azhal, and Iyam. The imbalance affects the Keelnokkukal, which in 
turn affect the seven Udal thathukkal. Saram gets affected and there is loss of 
appetite. Seiner also get affected with the net result even if the patient eats more 
nourished food (Polyphagia), there won‟t be any improvement in health. 
An imbalance in Iyam does imply an imbalance in other two kutrams too and 
causes derangement of dasavayu and seven Udal thathukkal which causes the disease 
and other complications. 
                                                                                        REVIEW OF LITERATURE 
 
ANTI DIABETIC ACTIVITY OF ELATHY URUNDAI  Page 23 
 
3.2.2.   MODERN ASPECT OF THE DISEASE 
Diabetes mellitus 
Diabetes mellitus is one of the most common endocrine disorders. It is a 
clinical syndrome characterized by hyperglycaemia with or without glycosuria, 
resulting from an absolute or relative deficiency of insulin, affecting carbohydrate, 
protein and fat metabolism. It may be due to impairment of insulin production or its 
release by Beta cells of islets of Langerhans. Long standing metabolic derangement is 
associated with functional and structural changes in many organs especially the 
vascular system leading to Diabetic retinopathy, neuropathy and nephropathy and 
atherosclerosis. 
The three major types of Diabetes mellitus 
 Type 1 Diabetes. 
 Type 2 Diabetes. 
 Gestational Diabetes mellitus 
Type 1 diabetes mellitus 
 It is called as the insulin dependent, immune mediated or juvenile onset diabetes. 
People with this type of diabetes produce very little or no insulin. They need 
injections of insulin every day to control the glucose level in the blood. 
Type II diabetes 
 It is called as the non-insulin dependent diabetes. It is also known as late-onset 
diabetes and it is characterized by insulin resistance and relative insulin deficiency. 
Though the disease is highly genetic in origin some risk factors such as excess weight, 
inactivity, high blood pressure and poor diet plays a major role for its development.  
Gestational Diabetes mellitus (GDM) 
 It is the presence of high glucose level in the blood during pregnancy. It 
usually disappears after the pregnancy but the women and her children are at high risk 
of developing type II diabetes later in their life. 
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Complications
 [25]
 
 Virtually every tissue and organ is biochemically and structurally altered as a 
consequence of the hyperglycemia of diabetes and result in complications.   
 Two biochemical mechanisms appear to be involved in the development of 
many complications.    
(i) Non enzymatic glycosylation  
 It is the process by which glucose attaches to amino group of proteins without 
the aid of enzymes. That can cause structural and functional abnormalities of the 
involved proteins to form Advanced Glycation End Products (AGE), which cause 
microangiopathy, nephropathy. The concentration of Glycosylated Hemoglobin 
(HbA1C) in the blood is now used clinically as a measure of therapeutic control. 
(ii) Intracellular Hyperglycemia with disturbances in Polyol pathways  
 The second biochemical mechanism operates in the aorta, lens of the eye, 
kidney and peripheral nerves.  These tissues are endowed with an enzyme, aldoses 
reductase that facilitates the accumulation of sorbital and fructose in cells of the 
hyperglycemic patient.  As a result of the intracellular accumulation of sorbital and 
fructose an osmotic gradient is established and excessive amounts of water enter the 
cells from the extra cellular compartment.  The cells then swell and are damaged and 
contribute to neuropathy and cataracts.    
1. Diabetic ketoacidosis       
 It is a major medical emergency and serious cause of mortality principally in 
people with type 1DM.  It has a mortality rate of 6-10%.In newly diagnosed patients 
of type 1 DM there is failure of endogenous insulin and in NIDDM it is due to 
inadequate exogenous insulin or a stressful conditions like myocardial infarction, 
hyperthyroidism, pheochromocytoma, trauma, pregnancy, drugs like cocaine. In these 
conditions there is increase in production of counter regulatory hormones like 
epinephrine, cortisol, glucagon and growth hormone. 
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 The cardinal biochemical features are     
 1.hyperglycaemia      
 2.hyperketonaemia       
 3.metabolic acidosis 
Clinical features
 [26] 
        
  (i)  Polyuria, thirst, weight loss, weakness, nausea, vomiting, leg cramps, 
blurred vision and abdominal pain which is common in children   
  (ii)  The striking features are those of salt and water depletion, with loss of 
skin tone, furred tongue, cracked lips, tachycardia, hypotension and reduced intra 
ocular pressure. 
      (iii)  Cold extremities, tachycardia, air hunger (Kussmaul breathing), 
acetone odour in breath.  
      (iv) Hypothermia, confusion, drowsiness and coma.    
2. Hypoglycaemia: 
  It is the fall of blood glucose levels below 50-60mg/dl at which level 
symptoms occur in normal persons. Development of symptoms depends on the 
prevailing blood glucose levels and individual susceptibility.  
Symptoms of hypoglycaemia 
 Autonomic symptoms like palpitation, sweating, tremors, anxiety.  
 Neuroglycopenic symptoms: tiredness, dizziness, drowsiness, difficult to 
concentrate and dysphasia. 
 Lethargy, coma, convulsions  
 Permanent brain damage. 
 Sudden death due to cardiac arrhythmias („dead in bed‟ syndrome). 
3. Cardiovascular system 
 Macroangiopathy 
 Microangiopathy 
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4. Ocular complication 
 Diabetic Cataract 
 Diabetic Retinopathy 
 Glaucoma develops in 6% cases. 
5. Renal complications 
 Renal arteriosclerosis. 
 Pyelo nephritis - This is very common and may lead to chronic renal failure. 
 Micro albuminuria 
 Papillitis, Necroticans- The renal papillae will show necrosis, ultimately 
leading to viaemia. 
 Kimmelstiel – Wilson syndrome (K.W. syndrome)  
 This is develops in average 10 years duration clinically patient will present 
feature of nephritic syndrome.  
6. Diabetic neuropathy 
 This is an early and common complication affecting 39% of diabetic patients. 
Metabolic neuropathy develops due to hyperglycaemia and this subsides with proper 
control of Diabetes.  
 Peripheral neuritis (30%) 
 Autonomic imbalance 
 Diabetic amyotrophy 
 Charcot‟s joint 
7. Sexual and Genital Complications 
 Impotence and frigidity may develop erectile dysfunction in males is 
particularly important.  Balanitis and Balanoposthitis are common complications in 
males.  These are due to secondary infection as urine contains heavy amount of sugar 
and nitrogenous materials. Leucorrhoea may develop in females. 
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8. Pulmonary complications 
 Tuberculosis is very common in diabetes other infective complications like 
pneumonia, bronchopneumonia, pleurisy etc. 
9. Effect on pregnancy and neonates 
 There may be miscarriages and abortions, toxaemias of pregnancy, hydramios 
etc Herculian child may be born of diabetic mothers due to secretion of excess of 
growth hormone. 
10. Diabetic Foot 
 The foot is a frequent site for complications in patients with diabetes, so foot 
care is particularly important. Tissue necrosis is common reason for hospital 
admission in diabetics may end in amputation.     
Treatment 
Anti-Diabetic drugs 
Insulin
 [27]
 
  1. Insulin was first isolated from the Pancreas in 1922 by Banting and 
Best. Insulin is a polypeptide containing two chains of amino acids linked by disulfide 
bridges having molecular weight of 5808.       
  2. It is synthesized in the endoplasmic reticulum of the β cells as 
Preproinsulin that give rise to Proinsulin which undergoes peptic cleavage to form 
Insulin and C-peptide. C-peptide connects  and β chains.    
  3.The half-life of insulin in the circulation in human is about 5 minutes and 
cleared from circulation within 10-15 minutes and stored in beta cell granules and 
discharged into interstitial fluid under appropriate stimulus, enters portal circulation 
and liver traps 50-60% and remaining enter peripheral circulation. It is degraded by 
enzyme Insulinase in liver, in the kidneys and muscles. 
Preparations of insulin 
 Insulin preparation differs in their source and duration of action. Based on the 
ource they may be classified as bovine, porcine and human insulin.            
                                                                                        REVIEW OF LITERATURE 
 
ANTI DIABETIC ACTIVITY OF ELATHY URUNDAI  Page 28 
 
                                      Table No.1. Insulin types 
Conventional insulin  
 Short and rapid acting 
 
 Intermediate acting 
 
 Long acting 
Regular  
Semilente 
Lente 
Isophane insulin(NPH) 
Ultralente 
Protamine zinc insulin 
Highly purified insulins  
 Single peak insulin 
 
 Monocomponent insulins 
Regular 
Lente  
Regular  
Lente  
Human insulin Regular  
Lente 
Ultralente 
Isophane 
Insulin analogs 
 Rapid acting 
 
 Long acting 
 
Insulin lispro 
Insulin aspart 
Insulin glargine 
Insulin detemir 
Insulin mixtures Combinations of 20-50-% regular with 80-
50% NPH (Neutral Protamine Hagedorn) 
insulins. 
 
Figure no.1. Insulin 
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Insulin and its doses
 [28] 
Regular/plane insulin   -  SOLUBLE INSULIN 40 IU/ml 
LENTE INSULIN, ISOPHANE  
INSULIN, PROTAMINE ZINC       -   40 IU/ml inj for   sub-cutaneous use. 
INSULIN  
Highly purified regular  -  ACTRAPID MC-40,100 IU/ml inj 
Highly purified lente   -  LENTARD, MONOTARD MC 40 
Iu/ml 
Highly purified NPH   -  INSULATARD-40/ml 
Mixture of regular + NPH insulin -  MIXTARD 40IU/ml 
Human actrapid   - regular 40,100 IU/ml inj 
Human monotard   - Lente 
Human insulatard   -  NPH 
Human mixtard   -  Regular NPH 
Humalog100U/ml inj   -  NOVALOG 100 IU/ml inj, FLEXPAN 
100 IU/ml (30ml vial) 
Oral Anti-Diabetic Drugs
 [29] 
 
The main disadvantage of insulin is the need for injection. The advance of oral 
hypoglycaemics came as a boon to millions of NIDDM patients with early and mild 
diabetes. Sulfonylureas were available in 1950s. We now have 5 groups of oral 
hypoglycaemics  
 sulfonylureas,  
 biguanides,  
 meglitinides,  
 alpha glucosidase inhibitors  
 Thiazolidinediones.  
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Table No.2. Mechanism of action and adverse effects of oral antidiabetic drug 
                  Mechanism of action and adverse effects of oral antidiabetics 
Oral antidiabetics Major mechanism Adverse effects 
Sulfonylureas ↑ insulin release from 
pancreas 
↑ tissue sensitivity to 
insulin 
Hypoglycaemia 
Cholestatic jaundice 
Disulfiram like reaction 
Biguanides  ↓ hepatic gluconeogenesis 
↑ tissue sensitivity  insulin 
Diarrhea, metallic taste, 
rarely lactic acidosis 
Meglitinides  ↑ insulin release from 
pancreas 
Hypoglycaemia 
 
Thiazolidinediones ↑ glucose transport into 
tissues 
↓ hepatic gluconeogenesis 
Weight gain, oedema, may 
precipitate CCF, risk of 
hepato toxicity  
α glucosidase inhibitors ↓ glucose absorption 
↓ hydrolysis of 
disaccharides 
Flatulence, diarrhoea, 
abdominal distension 
 
Status of anti-diabetic drugs 
For the patients with IDDM, insulin is the only treatment as there is insulin 
deficiency due to destruction of β cells. Sulphonylureas need functional β cells for 
their action and therefore are not useful in IDDM. Uncomplicated NIDDM patients 
not controlled by diet and exercise are given oral hypoglycaemics. Mild NIDDM 
patients with recent onset diabetes, age above 40 years at onset of diabetes, obese with 
fasting sugar less than 200 mg/dl are candidates for oral hypoglycaemics. 
Some of the other Siddha drugs used for diabetes mellitus 
 Navalkottai Chooranam    
 Seenthil Chooranam 
 Sirukurinchan Chooranam    
 Kompupagal Chooranam 
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 Thiripala Chooranam     
 Navathanya Chooranam 
 Santhiraganthi Chooranam    
 Maruthampattai kashayam 
 Atthiyathi kashayam     
 Aanandhabairava Mathirai 
 Mahalinga Mathirai     
 Sanjeevi kirutham 
 Meghaadi Kuligai     
 Karpoorathi Mathirai 
 Abragha parpam      
 Naga parpam 
 Velvanga parpam     
 Kaandha sendooram 
3.3   PHARMACOLOGICAL REVIEW 
Pharmacological study of Anti-Diabetic activity in animal models 
Models for insulin dependent diabetes 
1. Chemically induced diabetes 
It is the most commonly used animal model of the diabetes mellitus. It is 
classified into three categories that include agents that 
 Specifically damage the β-cell 
 Cause temporary inhibition of insulin production 
 Decrease the efficacy of insulin in target tissues 
 In general chemicals in the first category are of interest as they reproduce 
lesions resembling IDDM
[30]
. 
2. Alloxan – induced diabetes 
 Alloxan is a cyclic urea drug analog and it was reported to produce permanent 
diabetes in animals. 
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Mechanism of action 
 The mechanism by which it induces diabetes is not very clear. Alloxan is 
highly reactive molecule that is readily reduced to diuleric acid, which is then auto 
oxidized back to alloxan resulting in the production of free radicals. These free 
radicals damage the DNA of the β cells and cause cell death. Second mechanism 
proposed for alloxan is its ability to react with protein SH group, especially the 
membrane proteins like glucokinase on the β cells; finally resulting in cell necrosis 
however, there are major species differences in response to alloxan
[31]
.  
Procedure 
Animal models                                     Dose  
Rabbits (2 to 3 kg)    –  150 mg /kg 
Wistar Rats  (150-200gm)   _  100-175mg/kg 
Male beagle dogs (15-20kg)  –   60mg/kg 
Monkeys     –  65-200mg/kg 
 All the animals which are administered with alloxan receive glucose and 
regular insulin for one week and food ad libitum. Then single daily dose of 28 IU 
insulin is administered. There is a triphasic change in the blood glucose level. At first 
there is a hyperglycemia at 2 hrs, then hypoglycemic phase at 8 hrs and finally an 
increase at 24 hrs. 
3. Streptozotocin (STZ) - induced diabetes 
 STZ (2-deoxy-2-(3-methyl-3-nitrosourea) 1-D-glucopyranose) is a broad 
spectrum antibiotic produced from the Streptomyces achromogens. The Diabetogenic 
activity of STZ was first described by Rakieten
[32]
. 
Mechanism of causing β cell damage 
 By process of methylation  
 Free radical generation  
 Nitric oxide production  
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Procedure 
 STZ induces diabetes in all species of animals. 
Animal model                                      Dose   
Rats    - 50-60mg/kg 
Mice   - 175-200mg/kg 
Dogs   - 15mg/kg 
 After administration of the STZ the blood glucose level shows the triphasic 
change. Hyperglycemia at 1 hr, followed by hypoglycemia for 6hrs, and there is a 
stable hyperglycemia by 24-48 hrs. 
4. Hormone induced diabetes 
 Dexamethasone, a long acting glucocorticoid is used to produce diabetes. 
Dexamethasone is administered to the rats in the dose of 2-5 mg/kg twice daily over a 
number of days. 
5. Diabetes induced by the viral agents 
Viruses are thought to be one of the etiologic agents for IDDM. Viruses may 
produce Diabetes mellitus by 
 Infecting and destroying of β-cells in pancreas. 
 A less infecting or cytologic variant producing a comparable damage by 
eliciting immune auto reactivity to the β-cells. 
 Viruses producing systemic effect, not directly affecting β-cells. 
Various numbers of viruses are used to induce diabetes. They are RN picorno 
virus, coxsackie-B4 (CB4), mengo – 2T, encephalomylocarditis (emc-d and m 
variants), double stranded RNA viruses, reovirus and lymphocytic choriomeningitis 
virus (LMCV). Primary isolates of these human pathogenic agents are generally not 
pancreatotrophic or ilytic to mouse b-cells and must be adapted for growth either by 
inoculation into suckling mice or by passage in cultured mouse β-cells[33] . 
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6. Surgically induced diabetes 
Surgical removal of all or parts of the pancreas induce diabetes; in partial 
pancreatectomy more than 90% of the organ is removed to produce diabetes. 
Depending on the amount of intact pancreatic cells, diabetes may range in duration 
from a few days to several months. Total removal of the pancreas results in an insulin 
dependent form of diabetes, and insulin therapy is required to maintain experimental 
animals. The portion of the pancreas usually left intact following a subtotal pancreatic 
resection is typically the anterior lobe or a portion thereof
[34]
. 
 The use of pancreatectomy in combination with chemical agents, such as 
alloxan and STZ, produces a stable form of Diabetes mellitus in animals, such as cats 
and dogs, that does not occur when each procedure is applied an dependently. The 
combination therapy reduces the organ damage associated with chemical induction 
and minimizes the interventions, such as enzyme supplementation, necessary to 
maintain a pancreatectomized animal. 
7. Insulin antibodies-induced diabetes 
Giving bovine insulin along with CFA to guinea pigs produces anti-insulin 
antibodies. Intravenous injection of 0.25-1.0 ml guinea pig anti-insulin serum to 
rats induces a dose dependent increase in blood glucose levels up to 300 mg%. This 
unique effect to guinea pig anti-insulin serum is due to neutralization of endogenous 
insulin by the insulin antibodies. It persists as long as the antibodies are capable of 
reacting with insulin remaining in the circulation. Slow i.v. infusion or i.p. injection 
prolongs the effect for more than a few hours. However, large doses and prolonged 
administration are accompanied by ketonemia, ketonuria, glycosuria and acidosis and 
are fatal to the animals. After lower doses, the diabetic syndrome is reversible after a 
few hours
[35]
. 
3.4. PHARMACEUTICAL REVIEW 
Pharmaceutics is a discipline of pharmacy that deals with the process of 
turning a new chemical entity to be used safely and effectively by the patients. 
(Formulation of pure drug substance into dosage form) 
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  Siddha pharmaceutics has very minute chemical processes in it. It has several 
chemical processes like purification of raw substances, grinding them with herbal 
juices for several days and subjecting the ground material to fire by way of putam 
process. Medicines prepared according to the above methods undergo several 
chemical changes. 
Siddha medicines are classified into internal medicines (32) and external 
medicines (32). The drug taken for dissertation is in the form of Mathirai. Other 
names of Mathirai are Kuligai, Urundai, and Vattam. Mathirai comes under the 
category of internal medicines.
 
 
Purification of the drugs included 
Purification of the drugs is mainly done to remove the toxicities, impurities 
like soil, dust, clay present in the drugs. Also the drugs when subjected to heat like 
roasting or soaked in liquids undergo certain chemical reactions such as oxidation of 
toxic substances to non-toxic, reduction of some poisonous chemicals to non-
poisonous ones or undergo enzymatic reactions. In these ways, not only the toxicities 
and impurities are removed but also enhanced the potency of the drugs. 
Concept and Terminology of pills 
It is a pill prepared from a finely ground paste of drugs. The term Mathirai is 
the most fitting category of medicines as besides indicating the form of medicine that 
is pills. It also means that the minimal dosage unit is one pill (Mathirai means 1 unit). 
Preparation of Mathirai includes various processes like, extraction of juices, making 
decoction, preparing powders, grinding pastes and rolling into pills or pressing into 
tablets. The raw drugs are dried in the sun or shade and the drugs which are aromatic 
are to be roasted separately.  The raw drugs are purified and grounded separately, then 
the compounded drug be grounded in a mortar for the prescribed period with the 
addition of prescribed juices and decoctions.  
If green drugs are to be added they should be made into fine paste before 
being used. Vegetable drugs which require frying are fried and powdered. However, 
scented herbal drugs like cinnamon leaves and cloves, cinnamon bark are dried only 
in shade as otherwise their volatile oil are lost by drying. 
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The individual drugs should be separately weighed after being powdered and 
then taken in the prescribed ratio. After the pill mass has been prepared by following, 
the processes outlined in the recipe, it is convenient to roll it into long uniform pencils 
and then cut into bits of uniform length to give suitable pill weight and then rolling a 
pill from each piece. This is a fast process to prepare uniform pills as pinching and 
rolling every time is invariably a tiresome, tedious and time consuming messy 
process. The pill mass when rolled between the fingers should not stick. This is the 
correct consistency for rolling into pills. The pills should be always dried in a warm, 
dry shady place and never under the sun because volatile matters in the pills are easily 
lost and photochemical breakdown of active principles are faster in sunlight of the 
tropics.  If the pill mass sticks to the fingers, a speck of ghee may be smeared on the 
fingers. Pills should be well dried in shade
 [36]
. 
Storage and Usage 
Almost all the Mathirai contain highly active ingredients. Hence they should be 
preserved in well stopper glass vials with relevant labels and instructions. If the 
Mathirai lose their natural shape, colours, smell, taste etc, it is not advisable to 
consume them. If properly stored, we can keep them for a year. 
 Preparation of Mathirai in Manufacturing Units 
In the manufacturing unit, Chooranam is compressed into tablets. Tablets are 
unit forms of solid medicinal substances with or without suitable diluents prepared by 
compressing and they are mostly discoid in form. Binders like Gum acacia, lubricants 
like liquid paraffin and disintegrators like Talcum powder are used. Chooranam is 
first prepared according to the above procedures. Then the ingredients are mixed with 
in the form of granules before compressing as tablets. Too much fine powder refuses 
to form satisfactory tablets and so they must be mixed with some adhesive substances 
or binders such as gum acacia. To prevent the sticking of the tablets to the punches 
and dyes a lubricant like liquid paraffin is added. If the tablet is to dissolve quickly, a 
disintegrator like talcum powder is added
 [37]
. 
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Shelf life of the drugs 
The shelf life of the drugs depends on the effectiveness of the preparation. The 
efficacy, smell, taste and appearance of the drugs gradually change as time goes on 
resulting in reduced potency thereby the desired effect is not attained. But some drugs 
appear to be good externally in spite of reduced efficacy. So they should not be 
considered for consumption and should be discarded. The shelf life of Mathirai is 1 
year. According to recently published guidelines by Ayush, the shelf life period of 
Mathirai is 2 years.  Also the following are the analytical parameters of specifications 
of Mathirai
[38] 
. 
Table No.3. Testing parameters for Mathirai-AYUSH guidelines
 [39]
  
S.No Tests 
  1 Description, Colour, Odour 
  2 Weight Variation 
  3 Disintegration Time (Not more than 15 
minutes) 
  4 Identification TLC/ HPTLC/GLC 
  5 Assay 
  6 Test for heavy/toxic metals 
Mercury 
Arsenic 
Cadmium 
Lead 
    7 Microbial Contamination 
Total Bacterial count 
Total Fungal count 
     8 Test for specific pathogen 
E.coli 
Salmonella species 
Pseudomonas aeruginosa 
Streptococcus aureus 
    10 Test for aflatoxins B1, B2, G1, G2 
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Traditional tests for Mathirai  
 Characters: 
 Non sticky on rolling. 
 No cracks over the surface after drying. 
 Shall be rolled uniformly over the plane surface.  
Based on these characters the drug is assessed as the appropriate one for 
medication. 
3.5. LATERAL RESEARCH 
Cassia Auriculata (Anti-bacterial and Anti-oxidant activity) 
 The ethanol, methanol and aqueous extracts of dry and fresh flower possess 
Anti-Bacerial activity and also shows the presence of phytochemicals such as 
terpinoids, tanins, flavonoids, saponin, cardiac glycosides, and steroids were 
observed. 
 The Anti-Oxidant activity of ethanoland methanol extract of Cassia auriculata 
flowers were studied in two assays based on the decolorization of the radical 
monocation of 2,2′-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) and 
1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging method. It showed anti-
oxidant activity in both the assays
 [40]
. 
Syzygium Aromaticum (Antibacterial activity and Hepatoprotetive activity) 
                 Methanolic extract of clove showed maximum zone of inhibition 24mm 
against S. aureus while minimum was 19 mm against P. aeuginos. Ethanolic extract of 
clove showed maximum zone of inhibition 20 mm against P. aeuginosa while 
minimum was 18mm against E. coli.  
                50 % ethanolic extract of S. aromaticum can attenuate liver necrosis in 
animal model. Liver injury was induced by single intraperitoneal injection of 
thioacetamide (400 mg/kg b. w.). Oral administration of the extract (800 mg/kg b. w.) 
for three consecutive days could significantly ameliorate the changes associated with 
hepatic injury, particularly the levels serum biochemical markers of liver injury and 
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oxidative stress. The protective action may be attributed to eugenol, which has been 
shown to be present in the test extract
 [41]
. 
Elettaria Cardamomum 
Anti-oxidant and anti-microbial activities of essential oil and various oleoresins 
of Elettaria cardamomum (seeds and pods) 
Elettaria cardamomam compares the effect of the different extraction solvent 
used (chloroform.methonol, ethanol and diethyl ether) on the Anti-oxidant, Anti-
microbial activities of essential oils and oleoresins
 [42]
. 
Cinnamomum tamala (Anti-Bacterial activity) 
Cinnamomum tamala and their chemical constituents were investigated in this 
study
 [43] 
Tinospora Cardifolia (Anti-ulcer and anti-oxidant activity) 
Tinospora cordifolia was tested for its anti-ulcer and anti-oxidant activity in 
rats, pepticare studied on gastric secretion and gastric ulcers in pylorus-ligation and 
gastric ulcers in pylorus-ligation and ethanol-induced gastric mucosal injury in rats
[44]
  
Nelumbo Nucifera 
Cardioprotective effect of Nelumbo nucifera flower extract Agaistisoproterinol 
induced oxidative stress in male albino Swiss rats 
The present study investigate the cardioprotective effect of Nelumbo nucifera 
flower in isoproterinol induced rats. The positive hypertrophy response of 
isoproterinol caused a severe oxidative stress in the myocardium through increased 
lipid peroxidation. Nelumbo nucifera was administered intraperitonealy at a dose of 
200mg/kg for a period of 30days
 [45]
.
 
Asparagus racemosus(Hypolipidemic and anti oxidant activity) 
It is reducing the cholesterol levels and as an anti-oxidant in 
hypercholesteremic rats.
[46]
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4. MATERIALS AND METHODS 
Preparation of the Drug 
Selection of drug  
 The trial drug “Elathy Urundai” was prepared as per Siddha literature 
“Sarabenthirar vaithiya muraigal.” 
Ingredients 
Elam (Elettaria cardamomum)   -   1 Palam (35gm) 
Kirambu (Syzygium aromaticum)   -   1 Palam (35gm) 
Ilavangap pathiri (Cinnamomum tamala)  -   1 Palam (35gm) 
 Aavarai panchangam (Cassia auriculata)  -   1 Palam (35gm) 
           Seenthir kizhangu (Tinospora cardiofolia)  -   1 Palam(35gm) 
           Thannervittan kizhangu (Asparagus racemosus) -   1 Palam(35gm) 
           Thamarai valaiyam (Nelumbo nucifera)  -   1Palam (35gm) 
            Butter milk      -   50ml 
Collection of the drugs 
 The drugs such as Elam, Kirambu, Ilavangappathiri, Aavarai panchangam, 
Seenthir kizhangu, Thamaraivalaiyam were procured from Ramasamy chettiyar Raw 
Drug Stores at Parry‟s corner, Chennai.  
     Butter milk from Departmental store. 
     Ref No:GSMC/PGGM/061-067/2014-2017.  
Identification and Authentication 
All the raw drugs were identified and authenticated by the Botanist and 
experts of Gunapadam Department (Pharmacology) at Government Siddha Medical 
College, Arumbakkam, Chennai 106. 
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The specimen samples of the identified raw drugs were preserved in the 
laboratory of P.G Gunapadam for future references. 
Method of purification   
Elam 
All the impurities like sand and dust were removed, then slightly roasted and  
powdered.  
Kirambu 
All the impurities like sand and dust and the flower buds were removed, then 
slightly roasted and powdered.  
Ilavangappathiri 
Pale coloured and infected leaves were removed, dried and powdered. 
Aavarai panchangam 
All the impurities like sand and dust were removed, then slightly roasted and 
powdered.  
Seenthirkizhangu 
Soaked in water, skin and the veins were removed then dried and powdered.  
Thannervittankizhangu 
Soaked in water, skin and the veins were removed then dried and powdered. 
Thamaraivalaiyam 
All the impurities like sand and dust were removed, then slightly roasted and 
powdered.  
Method of preparation  
The Purified drugs were ground separately to powder and powder was sieved 
through a white cloth (vasthrakayam) to get the fine Choornam then the Choornam 
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was taken in the stone mortar and ground with butter milk to get a paste. Make tablets 
from the paste and allow it to dry. 
Preservation 
 The medicine was preserved in a clean, air tight container. 
Administration of the drug 
Form of the medicine   :  Pills 
Route of administration  :  Enteral 
Dose     :  2 pills 
Time of administration  :  2 times a day 
Indication    :  Diabetes and Polyuria.  
 
Ingredients of Elathy Urundai 
  
 
 
 
 
 
 
 
 
 
              Figure No.1           Figure No.2 
 
Elettaria cardamomum 
Syzygium aromaticum 
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Standardisation of the drug   
World Health Organization (WHO) has appreciated the importance of 
medicinal plants for public health care. The process of evaluating the quality and 
purity of herbal drugs by means of various parameters like physical, chemical and 
biological observation is called standardization. Standardization of the this drug 
comes under the following categories 
 Physio-chemical analysis 
 Phyto chemical analysis 
 Bio chemical analysis 
Organoleptic evaluation 
The Organoleptic characters of the sample were evaluated which include 
evaluation of the formulation by its colour, odour, size etc. 
Colour examination 
Ten tablets were taken into watch glasses and positioned against white back 
ground in white tube light. Its colour was observed by naked eye and results are 
noted. 
Odour examination 
Ten numbers of tablets were smelled individually. The time interval among 
two smelling was kept two minutes to overturn the effect of previous smelling. Odour 
of  Elathy Urundai was noted in results table. 
Size examination 
The diameter of ten tablets was measured by Vernier caliper. The mean value 
of diameter was noted. 
 Physio-Chemical investigation 
Physico‐chemical studies like total ash, water insoluble ash, acid Insoluble 
ash, loss on drying at 105°C and pH were done at, Central Research Institute, 
Chennai. 
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Solubility Test 
A pinch of the sample (Elathy Urundai) was taken in a dry test tube and 
shaken well with distilled water. A little amount of the sample (Elathy Urundai) is 
shaken well with con. HCl and then Con. H2SO4. Solubility was observed.  
Determination of Total Ash 
About 2 g of the ground drug (Elathy Urundai) was accurately weighed in a 
silica dish and incinerated at a temperature not exceeding 450º until it was free from 
carbon, cooled and weighed. The percentage of ash with reference to the air-dried 
drug was calculated. 
Determination of Water Soluble Ash 
Total ash was heated up to 600
0
C with 25 ml of distilled water for 10 minutes 
and the residue was ignited in the furnace to get a constant weight. And the weight 
was calculated. 
Determination of Acid Insoluble Ash 
The ash obtained was boiled for 5 minutes with 25 ml of dilute hydrochloric 
acid and insoluble matter was collected in an ash-less filter paper, washed with hot 
water and put up in flames to constant weight. The percentage of acid-insoluble ash 
with reference to the air dried drug was noted.   
Determination of Moisture Content (Loss on Drying)  
This procedure was done to determine the amount of volatile matter in the 
drug. A sample of 10 gram of the drug (Elathy Urundai) was placed in a tarred 
evaporating dish after accurately weighting without preliminary drying. The dish was 
dried at a temperature of 105
0
C for about 5 hours and again weighed. The drying and 
weighing procedure was repeated again and again until the difference between two 
successive weights was not more than 0.25%. And the weight was calculated. 
pH value 
Potentiometrically pH value was determined by a glass electrode and a pH 
meter. The pH of the Elathy Urundai was written in results column.  
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Tablet Disintegration test 
Each Elathy Urundai was placed in each of the six tubes of the basket present 
in the disintegration apparatus. The apparatus was operated by using water as the 
immersion fluid maintained at 35-39 °C. At the end of 30 min, the basket is lifted 
from the fluid and the state of the tablet is observed. The disintegration time of Elathy 
Urundai was recorded
[47]
. 
Weight variation test 
It was carried out to make sure that, each number of tablets contains the proper 
amount of drug. The test was carried out by weighing the 20 tablets individually using 
analytical balance, then the average weight was calculated and comparing the 
individual tablet weights to the average
[48]
. 
The percentage of weight variation is calculated by using this formula.  
 % of wt. variation =    Individual wt – Average wt  x 100 
 Average wt. 
 
Table No. 4.  Weight variation limits of Tablets (IP) 
Average weight of tablets Maximum percentage of weight 
difference allowed 
80 mg or less ±10.0 
Between 80 mg and 250 mg ±7.5 
250 mg and more ±5.0 
 
Phytochemical analysis 
The Phytochemical screening of the extract gives general idea regarding the 
nature of chemical constituents present in the crude drug. The phytochemical tests 
were done as the method illustrated in
[49]
. 
Test for Alkaloids 
A small portion of solvent free extracts was stirred separately with few drops 
of dilute hydrochloric acid and filtered & tested carefully with various alkaloidal 
reagents. 
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Mayer’s reagent  - Cream precipitate 
Dragendroff’s reagent - Orange brown precipitate 
Hager’s reagent  - Yellow precipitate 
Wagner’s reagent  - Reddish brown precipitate 
Test for Carbohydrates and Reducing Sugars 
The minimum amount of extracts was dissolved in 5ml of distilled water & 
filtered. The filtrate was subjected to test for carbohydrates & glycosides. 
a) Molisch’s test 
The filtrate 1 ml was treated with 2-3 drops of 1% alcoholic alpha naphthol& 
2ml concentrated sulphuric acid was added along the sides of test tube. Violet ring 
was observed at the junction of 2 layers which showed the presence of carbohydrate. 
b) Benedict’s test  
The filtrate 1 ml was treated with Benedict‟s reagent and heated gently. 
Orange red precipitate indicates the presence of reducing sugars. 
c) Fehling’s test  
The filtrate 1 ml was treated with equal volume of Fehling‟s solution A and B 
and heated gently. Orange red precipitate indicates the presence of reducing sugars. 
Test for Glycosides 
The extract was hydrolyzed with dil. HCl and subjected to test for glycosides. 
a) Modified Borntrager’s test 
To the hydrolysate extract, 1 ml of Ferric chloride solution was added and 
immersed in boiling water for about 5 min. The mixture was cooled and extracted 
with equal volume of benzene. The benzene layer was separated and treated with 
ammonia solution. Formation of rose pink colour in the ammoniacal layer indicates 
the presence of Anthranol glycosides. 
b) Legal’s test 
The hydrolysate extract was treated with Sodium nitropruside in pyridine and 
sodium hydroxide. Formation of pink to blood red colour indicates the presence of 
Cardiac glycosides.  
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Test for Saponins 
The extract 0.5 ml was shaken with 5 ml distilled water. The presence of 
saponins was indicated by formation of copious lather. 
Test for Tannins 
Gelatin test 
To the extract, 1% gelatin solution containing sodium chloride was added. 
Formation of white precipitate indicates the presence of tannins. 
Test for Phenolic compounds 
To 0.5 ml of extract, 1 ml of alcoholic ferric chloride solution was added. 
Formation of bluish green or bluish black indicates the presence of Phenolic 
compounds. 
Test for Phytosterol 
Ferric chloride – acetic acid test 
1 ml of extract was treated with 1 ml of chloroform and then, 2 ml of ferric 
chloride acetic acid reagent was added followed by 1 ml of conc. sulphuric acid. 
Appearance of reddish pink colour shows the presence of phytosterol. 
Test for Diterpenes 
Copper acetate test 
1 ml of extract was dissolved in water and treated with 3-4 drops of Copper 
acetate solution. Formation of emerald green colour indicates the presence of 
diterpenes. 
Test for Triterpenes 
Salkowski’s test 
1 ml of extract was treated with 1 ml of chloroform followed by 1 ml of conc. 
sulphuric acid, shaken and allowed to stand. Appearance of golden yellow colour 
shows the presence of triterpenes. 
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Test for Flavonoids 
a) Alkaline reagent test 
To 1 ml of extract, 1 ml of 10% sodium hydroxide solution was added. 
Formation of dark yellow colour indicates the presence of flavonoids. 
b) Lead acetate test 
To 1 ml of extract, 3-4 drops of 10% lead acetate solution was added. 
Formation of yellow precipitate indicates the presence of flavonoids. 
c) Ferric chloride test 
To 1 ml of extract, 3-4 drops of ferric chloride solution was added. Formation 
of dark green colour indicates the presence of flavonoids. 
d) Shinoda test 
To 1 ml of extract, few mg of magnesium turnings was added followed by few 
drops of conc. hydrochloric acid and boiled for five minutes in a boiling water bath. 
Formation of red colour indicates the presence of flavonoids. 
Test for Proteins and Free Amino Acids 
a) Xanthoproteic test 
To 1 ml of extract, 3-4 drops of conc. nitric acid was added. Formation of 
yellow precipitate indicates the presence of proteins. 
b) Million’s test 
To 0.5 ml of extract, 2.5 ml of Million‟s reagent was added. Formation of 
white precipitate and the precipitate warmed indicates the presence of proteins. 
c) Biuret test 
 To 0.5 ml of extract, 2.5 ml of diluted Biuret reagent was added.  Appearance 
of purple colour or brick red precipitate showed the presence of proteins and free 
amino acids. 
Test for Quinones 
Sodium hydroxide test: To 0.5 ml of extract, 1 ml of 10% sodium hydroxide was 
added.  Appearance of blue or green or red colour shows the presence of quinones. 
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TLC/ HPTLC finger print studies  
HPTLC finger printing was carried out as per the reference
[50]
.
 
Preparation of spray reagent-vanillin-sulphuric acid reagent 
Vanillin (1g) was dissolved in ice cold ethanol (95ml).  Add to 5ml of 
cooled concentrated sulphuric acid. Ice was added and stirred well. The solution 
was stored in refrigerator.   
Chromatographic conditions  
Instrument     : CAMAG (Switzerland). 
Sample applicator    : Camag Linomat - IV applicator with N2 gas flow. 
Photo documentation System  : Digi store - 2 documentation system with Win Cat and 
                                                    video scan software.        
 
Scanner     : Camag HPTLC scanner - 3 (030618), Win Cats - IV. 
Development Chamber    : Camag HPTLC 10X10, 10 X 20 twin trough linear 
    development chamber. 
 
Quantity applied    : 5, 10 µl for extracts and 5 µl for standards 
Stationary phase                     : Aluminium plate pre-coated with silica gel 60 
     (E.  Merck) 
Plate thickness     : 0.2 mm. 
Mobile Phase                          : Chloroform extract - Toluene: Ethyl acetate (9:2).                                                                                         
Scanning wavelength     : 254 nm 
Laboratory condition     : 26 ± 5
o
C and 53 % relative humidity 
The plate was developed up to a height of 8 cm, air dried, spots were observed 
under the UV light at 254 and 366 nm. Finally the plates were derivatized using 
vanillin-sulphuric acid reagent heated at 105° till colour spots appeared.  
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Bio-Chemical analysis 
The bio-chemical analysis was done to identify the acid and basic radicals 
present in the Elathy Urundai. 
Preparation of extract 
 5g of Elathy Urundai was taken in a 250 ml clean beaker and 50 ml of 
distilled water was added, boiled well and allowed to cool and filtered in a 100 ml 
volumetric flask and made up to 100 ml with distilled water.  
Preliminary basic and acidic radical studies  
Test for basic radicals 
1. Test for Potassium 
 To a pinch of the Elathy Urundai 2 ml of Sodium nitrate and 2 ml of Cobalt 
nitrate solution in 30% glacial acetic acid was added and observed for the presence of 
yellow precipitate. 
2. Test for Calcium 
To 2 ml of Elathy Urundai extract, 2 ml of 4% Ammonium oxide solution was 
added and observed for the formation of white precipitate. 
3. Test for Magnesium 
To 2ml of Elathy Urundai extract, drops of Sodium hydroxide solution was 
added and watched for the appearance of white precipitate. 
4. Test for Ammonium 
To 2ml of Elathy Urundai extract few ml of Nessler's reagent and excess of 
Sodium hydroxide solution are added for the appearance of brown colour. 
5. Test for Sodium 
Hydrochloric acid was added with a pinch of the Elathy Urundai, made as 
paste and introduced into the blue flame of Bunsen burner and observed for the 
appearance of intense yellow colour.  
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6. Test for Iron (Ferrous) 
The Elathy Urundai extract was treated with Conc. HNO3 and Ammonium 
thiocyanate and waited for the appearance of blood red colour.   
7. Test for Zinc 
To 2 ml of the Elathy Urundai extract drops of Sodium hydroxide solution 
was added and observed for white precipitate formation.  
8. Test for Aluminium 
To the 2m1 of the Elathy Urundai extract sodium hydroxide was added in 
drops and changes are noted.  
9. Test for Lead 
To 2 ml of Elathy Urundai extract 2ml of Potassium iodide solution was 
added and noted for yellow coloured precipitate.  
10. Test for Copper 
a. A pinch of Elathy Urundai was made into a paste with con. HCl in a watch 
glass and introduced into the non-luminous part of the flame and noted for blue colour 
appearance. 
b. To 2 ml of Elathy Urundai extract excess of Ammonia solution was added 
and observed for the appearance of blue coloured precipitate.  
11. Test for Mercury 
 To 2m1 of the Elathy Urundai extract sodium hydroxide solution was added 
and noted for yellow precipitate formation.  
12. Test for Arsenic 
 To 2 ml of the Elathy Urundai extract 2ml of Sodium hydroxide solution was 
added and observed for brown or red precipitate and noted.  
Test for acid radicals 
1. Test for Sulphate 
 To   2 ml of the Elathy Urundai extract 5% of Barium chloride solution was 
added and observed for the appearance of white precipitate.  
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2. Test for Chloride 
 The Elathy Urundai extract was treated with Silver nitrate solution and 
observed for the appearance of white precipitate. 
3. Test for Phosphate 
         The Elathy Urundai extract was treated with Ammonium molybdate and conc. 
HNO3 and observed for the appearance of yellow precipitate. 
4. Test for Carbonate 
        The Elathy Urundai extract was treated with conc.HCl and observed for the 
appearance of effervescence. 
5. Test for Fluoride & Oxalate 
To 2ml of Elathy Urundai extract 2ml of dil.acetic acid and 2ml calcium 
chloride solution was added and heated and watched for cloudy appearance. 
6. Test for Nitrate 
 To 1 gm of the Elathy Urundai, Copper turnings was added and again 
conc.H2SO4 was added, heated and the test tube was tilted vertically down  and 
observed for any changes. 
Microbial load  
Availability of bacterial load 
Enumeration of bacteria by plate count – agar plating technique 
 The plate count technique is one of the most routinely used procedures 
because of the enumeration of viable cells by this method
[51]
.  
Principle 
 This method is based on the principle that when a material containing 
bacterium is cultured, every viable bacterium develops into a visible colony on a 
nutrient agar medium. The numbers of colonies therefore are the same as the number 
of organisms contained in the Elathy Urundai. 
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Dilution 
 A small measured volume of Elathy Urundai  is mixed with a large volume of 
sterile water called the diluent or dilution blank.  Dilution is usually made in multiples 
of ten. A single dilution is calculated as follows: 
              Volume of the sample 
   Dilution =  
     Total volume of the sample and the diluents 
 
Requirements 
 Sample or Bacterial suspension 
 9 ml dilution blanks (7) 
 Sterile petri dishes (12) 
 Sterile 1 ml pipettes(7) 
 Nutrient agar medium (200 ml) 
 Colony counter  
Procedure 
1. Label the dilution blanks as 10-1, 10-2, 10-3, 10-4, 10-5, 10-6, 10-7. 
2. Prepare the initial dilution by adding 1 ml of the Elathy Urundai extract 
into a 9 ml dilution blank labelled 10
-1
 thus diluting the sample 10 times. 
3. Mix the contents by rolling the tube back and forth between hands to 
obtain uniform distribution of organisms. 
4. From the first dilution transfer 1 ml of the suspension while in motion, to 
the dilution blank 10
-2
 with a sterile and fresh 1 ml pipette diluting the 
original specimen to 100 times. 
5. From the 10-2 suspension, transfer 1 ml of suspension to 10-3 dilution blank 
with a fresh sterile pipette, thus diluting the original sample to 1000 times. 
6. Repeat this procedure till the sample has been diluted 10,000,000 times, 
every time using a fresh sterile pipette. 
7. From the appropriate dilutions transfer 1ml of suspension while in motion, 
with the respective pipettes, to sterile petri dishes. Three petri dishes are to 
be used for each dilution. 
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8. Approximately 15 ml of the nutrient medium is added, melted and cooled 
to 45
0
c, to each petri dish containing the diluted Elathy Urundai extract. 
Mix the contents of each dish by rotating gently to distribute the cells 
throughout the medium. 
9. Allow the plates to solidify. 
10.  Incubate these plates in an inverted position for 24-48 hours at 370c. 
Observation 
 Observe all the plates for the appearance of bacterial colonies. Count the 
number of colonies in the plates. 
 Calculate the number of bacteria per ml of the original suspension as follows: 
                Number of colonies (average of 3 repleates) 
 Organisms per millimetre =  
              Amount  plated × dilution 
 
Sophisicated instrumental analysis  
FT-IR (Fourier Transform Infra-Red) 
Model   : Spectrum one: FT-IR Spectrometer 
Scan Range   : MIR 450-4000 cm-1 
Resolution   : 1.0 cm-1  
Sample required : 50 mg, solid or liquid. 
It was the preferred method of infrared spectroscopy. FT-IR was an important 
and more advanced technique. It was used to identify the functional group, to 
determine the quality and consistency of the sample material and can determine the 
amount of compounds present in the sample. It was an excellent tool for quantitative 
analysis
 [52]
. 
FT-IR was the most advanced and the major advantage was its 
 Speed 
 Sensitivity 
 Mechanical Simplicity 
 Internally Calibrated. 
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In FT-IR infrared was passed from a source through a sample (Elathy 
Urundai). This infrared was absorbed by the sample (Elathy Urundai) according to 
the chemical properties and some are transmitted. The spectrum that appears denotes 
the molecular absorption and transmission. It forms the molecular fingerprint of the 
Elathy Urundai.  Like the finger print there was no two unique molecular structures 
producing the same infrared spectrum. It was recorded as the wavelength and the 
peaks seen in the spectrum indicates the amount of material present
 [53]
. 
SEM (Scanning Electron Microscope) 
 In scanning electron microscope high-energy electron beam was focused 
through a probe towards the sample (Elathy Urundai). Variety of signals was 
produced on interaction with the surface of the sample (Elathy Urundai). This results 
in the emission of electrons or photons and it was collected by an appropriate detector
 
[54]
.  
The types of signal produced by a scanning electron microscope include  
 Secondary electrons 
 back scattered electrons 
 characteristic x-rays, light 
 specimen current 
 Transmitted electrons. 
This gives the information about the sample and it includes external morphology, 
texture, its crystalline structure, chemical composition and it displays the shape of the 
sample
 [55]
. 
ICP-OES (Inductively Coupled Plasma Optic Emission Spectrometry) 
 Manufacturer: Perkin Elmer 
 Model:  Optima 5300 DV ICP-OES Inductively Coupled Plasma 
Spectrometer (ICP) 
Principle 
 An aqueous sample was converted to aerosols via a nebulizer. The aerosols are 
transported to the inductively coupled plasma which was a high temperature zone 
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(8,000– 10,000ºC). The analysts are heated (excited) to different (atomic and/or ionic) 
states and produce characteristic optical emissions (lights). These releases are 
separated based on their respective wavelengths and their strengths are measured 
(spectrometry). The intensities are proportional to the concentrations of analyses in 
the aqueous sample. The quantification was an external multipoint linear 
standardization by comparing the emission intensity of an unknown sample with that 
of a standard sample. Multi-element calibration standard solutions are prepared from 
single- and multi element primary standard solutions. With respect to other kinds of 
analysis where chemical speciation was relevant (such as the concentration of Ferrous 
Iron or Ferric Iron), only total essential concentration was analyzed by ICP-OES
 [56]
. 
Application 
 The analysis of major and minor elements in solution Elathy Urundai. 
Objectives 
 Determine elemental concentrations of different metals. 
 Learn principles and operation of the ICP-OES instrument. 
 Develop and put on a method for the ICP-OES sample analysis. 
 Enhance the instrumental conditions for the analysis of different elements 
probes the outer electronic structure of atoms. 
Mechanism  
 In plasma emission spectroscopy (OES), a Elathy Urundai solution was 
presented into the core of inductively coupled argon plasma (ICP), which generates 
temperature of approximately 8000°C. At this temperature all elements become 
thermally excited and emit light at their characteristic wavelengths. This light was 
collected by the spectrometer and passes through a diffraction grating that serves to 
resolve the light into a spectrum of its essential wavelengths. Within the spectrometer, 
this deflected light was then collected by wavelength and amplified to yield an 
strength of  measurement that can be converted to an elemental concentration by 
comparison with standardization values
[57]
. 
                                                                                     MATERIALS AND METHODS 
 
ANTI DIABETIC ACTIVITY OF ELATHY URUNDAI  Page 57 
 
 The Inductively coupled plasma optical emission spectrometric (ICP-OES) 
analysis was done in SAIF, IIT MADRAS, and Chennai-36 using Perkin Elmer 
Optima 5300 DV. 
Sample preparation 
 Inductively Coupled Plasma Spectroscopy techniques are the so-called "wet" 
sampling methods whereby Elathy Urundai are introduced in liquid form for analysis. 
 100 mg Elathy Urundai was occupied in a clean, dry test tube. To this, 3 ml 
Nitric acid was added and mixed well and allowed for few minutes untill the reactions 
were completed. And then, 25 ml of Refined water, was added to prepare digested 
solution.  
The digested Elathy Urundai  solution was shifted into plastic containers and 
labeled properly. It was completed in Bio-chemistry lab, Govt. Siddha Medical 
College, Chennai-106. 
FTIR (Fourier Transform Infrared Spectroscopy) 
 
                   
       Fig 2.1:   FTIR Instument 
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                 Fig 2.2:  FTIR Mechanism 
SEM – Scanning Electron Microscope 
     
 
 
 
 
 
 
 
 
 
      Fig 2.3: SEM Instument 
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Fig 2.4:   SEM Mechanism 
 
 
IC-POES (Inductively Coupled Plasma Optic Emission Spectrometry) 
 
 
 
Fig 2.5: ICP-OES Analyser (Perkin Elmer Optima 5300 DV) 
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TOXICOLOGICAL STUDIES 
Acute oral toxicity – OECD Guidlines – 423  
Introduction 
The acute toxic class method was a stepwise procedure with the use of 3 
animals of a single sex per step. Depending on the mortality and the moribund status 
of the animals, on average 2-4 steps may be necessary to allow judgment on the acute 
toxicity of the test substance. Morbid animals or animals obviously in pain or showing 
signs of severe and enduring distress shall be humanely killed and are considered in 
the interpretation of the test  results  in  the  same  way  as  animals  that  died  on  
test.  The method allows for the determination of an LD50 value only when at least 
two doses result in mortality higher than 0% and lower than 100%. 
Acute toxicity study was carried out as per OECD guideline (Organization for 
Economic Co – operation and Development, Guideline-423. The experimental 
protocol was approved by the Institutional Animal Ethical Committee (IAEC) under 
CPCSEA (Approval no: IAEC/XLIV/26/CLBMCP/2014) at C.L.Baid Metha College 
of pharmacy, Thuraipakkam, Chennai. 
Fig 2.6: Mechanism of ICP-OES analyser 
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Animal: Healthy wistar albino female rat weighing 200–220 gm. 
Principle 
It was the principle of the test that based on a stepwise procedure with the use 
of a minimum  number  of  animals  per  step,  information  was  obtained  on  the  
acute toxicity  of  the  test  substance  to  enable  its  classification.  The substance was 
administered orally to a group of experimental animals at one of the defined doses.  
The substance was tested using a stepwise procedure, each step using three animals of 
a single sex. Absence or presence of compound-related mortality of the animals dosed 
at one step will determine the next step, i.e.; − no further testing was needed – dosing 
of three additional animals with the same dose – dosing of three additional animals at 
the next higher or the next lower dose level. The method will enable a judgment with 
respect to classifying the test substance to one of a series of toxicity classes
 [58]
.   
Studied carried out at three female rats under fasting condition, signs of 
toxicity was observed for every one hour for first 24 hours and every day for about 14 
days from the beginning of the study. 
Methodology 
Selection of animal species 
The preferred rodent species was rat, although other rodent species may be 
used.  Healthy young adult animals of commonly used laboratory strain Swiss albino 
rat were obtained from Animal house of King Institute, Guindy, Chennai. Females 
should be nulliparous and non-pregnant.  Each animal at the commencement of its 
dosing should be between 8 and 12 weeks old and its weight should fall in an interval 
within ±20 % of the mean weight of the animals.  The studies were conducted in the 
animal house of C.L.Baid Metha College of pharmacy, Thuraipakkam, Chennai. 
Housing and feeding conditions  
   The  temperature  in  the  experimental  animal  room  should  be  22ºC  
(+3ºC). Although  the  relative  humidity  should  be  at  least  30%  and  preferably  
not  exceed  70% other than during room cleaning the aim should be 50-60%. 
Lighting should be artificial, the sequence being 12 hours light, 12 hrs dark. For 
feeding, conventional laboratory diets may be used with an unlimited supply of 
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drinking water. Animals may be grouped and tagged by dose, but the number of 
animals per cage must not interfere with clear observations of each animal.   
Preparation of animals   
   The animals are randomly selected, marked to permit individual identification, 
and kept in their cages for at least 7 days prior to dosing to allow for acclimatization 
to the laboratory conditions. 
Experiment procedure 
Administration of doses 
Elathy Urundai was prepared as per the classical Siddha literature was 
suspended in 2% CMC with uniform mixing and was administered to the groups of 
Wistar albino rats. It was given in a single oral dose by gavages using a feeding 
needle. Animals were fasted prior to dosing. Following the period of fasting, the 
animals were weighed and then the test substance was administered. After the 
substance has been administered, food was withheld for a further 3-4 hours. The 
principle of laboratory animal care was followed. Observations were made and 
recorded systematically and continuously observed as per the guideline after 
substance administration.  
The visual observations included skin changes, mobility, aggressiveness, 
sensitivity to sound and pain, as well as respiratory movements. They were deprived 
of food, but not water 16–18 hours prior to the administration of the test suspension. 
Finally, the number of survivors were noted after 24 hours and these animals were 
then maintained for a further 14 days and observations made daily. The toxicological 
effect was assessed on the basis of mortality.  
Number of animals and dose levels 
Since this Elathy Urundai has been under practice for long time and likely to 
be non-toxic, a limit test at one dose level of 2000 mg/kg body weight will be carried 
out with 6 animals   (3 animals per step). 
Duration of Study :    48 hours 
Evaluation  :   14 Days 
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Limit test 
The limit test was primarily used in situations where the experimenter has 
information indicating that the test material was likely to be nontoxic, i.e., having 
toxicity only above regulatory limit doses. A limit test at one dose level of 2000 
mg/kg body weight was carried out with three animals per step. The test substance-
related mortality was not produced in animals, so further testing at the next lower 
level need not be carried out.  
Observations 
 The animals were observed individually after dosing at least once during the 
first 30mins and periodically during the first 24 hours. 
 Special attention: First 1-4 hours after administration of drug.  
 It was observed daily thereafter for a total of 14 days, except when they 
needed to be removed from the study and killed humanely for animal welfare 
reasons or are found dead. 
a. Mortality 
Animals will be observed intensively at 0.5, 2.0, 4.0, 6.0, 12.0, 24.0 and 48.0 
hours following drug administration on day 1 of the experiment and daily twice 
thereafter for 14 days.   
b. Body weight 
Body weights will be recorded at Day 1, 2, 7 and 14 of the study 
c. Cage-side observation 
These include changes in skin and fur, eyes and mucous membranes and also 
respiratory, circulatory, autonomic and central nervous systems, somatomotor activity 
and behavioral patterns. Attention should be directed to observations of tremors, 
convulsions, salivation, diarrhoea, lethargy, sleep and coma. 
d. Gross necropsy 
All animals (including those which die during the test period are removed 
from the study) will be subjected to gross necropsy. Gross necropsy includes 
examination of the external surface of the body, all orifices, cranial, thoracic and 
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abdominal cavities and their contents, brain, eye, thymus, lungs, heart, spleen, liver, 
kidneys, adrenals, testes and uterus of all animals. 
Histopathology 
Microscopic examination will be carried out  in organs to show the evidence of 
any toxicity in gross pathology. 
Data and reporting 
All the data were summarised in tabular form showing the animals used, 
number of animals displaying signs of toxicity, the number animals found dead during 
the test or killed for humane reasons, a description and the time course of toxic effects 
and reversibility of necroscopic findings. 
Test substance and Vehicle  
In order to ensure the uniformity in drug distribution in the medium the 
suspension was made by mixing Elathy Urundai with 2% CMC solution and it was 
found suitable for dose accuracy.  
Justification for choice of vehicle 
The vehicle selected as per the standard guideline was pharmacologically inert 
and easy to employ for new drug development and evaluation technique
[59]
. 
Repeated dose 28 days oral toxicity of Elathy Urundai on rats– (OECD-407 
guidelines) 
Justification for Dose Selection 
 The results of acute toxicity studies in Wistar albino rats indicated that Elathy 
Urundai was non-toxic and no behavioral changes was observed up to the dose level 
of 2000 mg/kg body weight. On the basis of body surface area ratio between rat and 
human, the doses selected for the study were100mg/kg, 200 mg/kg and 400 mg/kg 
body weight. The oral route was selected for use because oral route was considered to 
be a proposed therapeutic route
 [60]
. 
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Preparation and administration of dose 
Elathy Urundai  at three doses respectively was suspended in 2 ml of 2% 
CMC in distilled water. It was administered to animals at the dose levels of 100, 200 
and 400 mg/kg. The test substance suspensions were freshly prepared every day for 
28 days. The control animals were administered vehicle only. Administration was by 
oral (gavage), once daily for 28 consecutive days. 
Methodology 
Randomization, Numbering and Grouping of Animals 
 Ten rats (Five Male and Five Female) were in each group randomly divided 
into four groups for dosing up to 28 days. Animals were allowed acclimatization 
period of 7 days to laboratory conditions prior to the initiation of treatment. Each 
animal was fur marked with picric acid. The females were nulliparous and non-
pregnant. 
Observations 
Experimental animals were kept under observation throughout the course of 
study for the following  
Body Weight  
Weight of each rat was recorded on day 0, at weekly intervals throughout the 
course of study and at termination to calculate relative organ weights. From the data, 
group mean body weights and percent body weight gain were calculated.  
Clinical signs 
 All animals were observed daily for clinical signs. The time of onset, intensity 
and duration of these symptoms, if any, were recorded. 
Mortality 
All animals were observed twice daily for mortality during entire course of 
study. 
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Functional Observations 
At the end of the 4
th
 week exposure, „sensory reactivity‟ to graded stimuli of 
different types (auditory, visual and proprioceptive stimuli), „motor reactivity‟ and 
„grip strength‟ were assessed. 
Laboratory Investigations 
Following laboratory investigations were carried out on day 29 in animals 
fasted over-night. Blood samples were collected from orbital sinus using sodium 
heparin (200IU/ml) for Blood chemistry and potassium EDTA (1.5 mg/ml) for 
Haematology as anticoagulant. Blood samples were centrifuged at 3000 r.p.m. for 10 
minutes. On 28th day of the experiment, 24 hours urine samples were collected by 
placing the animals in the metabolic cage with free access to tap water but no feed 
was given.  
 The urine was free from fecal contamination. Toluene was used as a 
preservative while collecting the sample. The sediments present in the urine were 
removed by centrifugation and the collected urine was used for biochemical 
estimations. On 29th day, the animals were fasted for approximately 18 hours, then 
slightly anesthetized with ether and blood samples were collected from the retro-
orbital plexus into two tubes: one with EDTA for immediate analysis of 
haematological parameters, the other without any anticoagulant and was centrifuged 
at 4000 rpm at 4 °C for 10 minutes to obtain the serum. Serum was stored at 20 °C 
until analyzed for biochemical parameters. 
Haematological Investigations 
Blood samples of control and experimental rats was analyzed for hemoglobin 
content, total red blood corpuscles (RBC), white blood corpuscles (WBC) count and 
packed cell volume (PCV).  
Biochemical Investigations 
Serum was used for the estimation of biochemical parameters. Samples of 
control and experimental rats were analyzed for protein, bilirubin, urea, BUN, 
creatinine, triglyceride, cholesterol and glucose levels was carried using standard 
methods. Activities of glutamate oxaloacetate transaminase/ Aspartate 
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aminotransferase (GOT/AST), glutamate pyruvate transaminase/ Alanine amino 
transferase (GPT/ALT) and alkaline phosphatase were estimated as per the 
colorimetric procedure.  
Urine analysis 
Urine samples were collected on end of treatment for estimation of normal 
parameters. The estimations were performed using appropriate methodology.  
Necropsy 
All the animals were sacrificed on day 29. Necropsy of all animals was carried 
out and the weights of the organs including liver, kidneys, spleen, brain, heart, and 
lungs were recorded. The relative organ weight of each animal was then calculated as 
follows; 
     Absolute organ weight (g) 
Relative organ weight = ___________________________________________ ×100 
    Body weight of animal on sacrifice day (g) 
Histopathology 
 Histopathological investigation of the vital organs was done. The organ pieces 
(3-5µm thick) of the highest dose level of 400 mg/kg were preserved and were fixed 
in 10% formalin for 24 hours and washed in running water for 24 hours. Samples 
were dehydrated in an auto technique and then cleared in benzene to remove absolute 
alcohol.  Embedding was done by passing the cleared samples through three cups 
containing molten paraffin at 50°C and then in a cubical block of paraffin made by the 
“L” moulds. It was followed by microtome and the slides were stained with 
Haematoxylin-eosin.  The organs included heart, kidneys, liver, ovary, pancreas, 
brain, spleen and stomach, of the animals were preserved they were subjected to 
Histopathological examination. 
Statistical analysis 
Findings such as clinical signs of intoxication, body weight changes, food 
consumption, hematology and blood chemistry were subjected to One-way ANOVA 
followed by Dunnet‟s multi comparision test using a computer software programme 
GRAPH PAD INSTAT-3 version. 
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PHARMACOLOGICAL ACTIVITY 
Anti-Diabetic activity of Elathy Urundai 
Screening the drug Elathy Urundai against Streptozotocin (STZ) induced 
Diabetes in Wistar albino Rats
 
Experimental Animals  
 The animals were divided into 5 groups each constituting 6 rats. Group I were 
normal rats, Group II were STZ (55 mg/kg b.w., i.p) induced diabetic rats. Group III 
STZ (55 mg/kg b.w., i.p) induced diabetic rats were treated with Glibenclamide 
5mg/kg b.w/p.o Group IV STZ (55 mg/kg b.w., i.p) induced diabetic rats were treated 
with Elathy Urundai 200mg/kg b.w/ p.o Group V STZ (55 mg/kg b.w., i.p) induced 
diabetic rats were treated with Elathy Urundai 400mg/kg b w/p.o for 28 days. 
Methodology 
Induction of Diabetes 
 Diabetes was induced in male Wistar albino rats aged 2–3 months (180–200 g 
body weight) by intra peritoneal administration of STZ (single dose of 55 mg/kg b.w) 
dissolved in freshly prepared 0.01 M citrate buffer, pH 4.5. 
  After injection the animals had food and water ad libitum and were given 5% 
glucose in their drinking water for the first 24 hours to counter any initial 
hypoglycemia. The development of diabetes was confirmed after 72 hours of the 
Streptozotocin injection. After 72 hours of STZ injection under mild anesthesia the 
blood was withdrawn from the tip of the tail of each rat and the blood glucose level 
was analyzed. Animals with more than 250 mg/dl was considered as diabetic.
 
 
 Fasting blood glucose levels was measured before the administration of 
extracts. The blood glucose levels were checked on 0th, 7th, 14th, and 21st day of the 
treatment period. Blood was collected from snipping of the rat tail. Blood glucose 
levels were measured
 [61]
. 
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Experimental Design 
 Diabetic rats were divided into three groups with six animals in each group. 
Table No.5.  Experimental design 
 
 
 
 
 
 
 
 
 
Blood collection 
 All the experimental rats were fasted overnight and the blood was withdrawn 
through puncturing retro orbital sinus on the 5
th
 day, 15
th
 day and 20
th
 day of post 
induction period to determine blood glucose level by GOD-POD kit method. The 
change in body weight was observed throughout the treatment period in experimental 
animals
 [62]
. 
Statistical Analysis 
All the values were expressed as Mean ± S.D. The differences between control 
and treatment groups were tested for significance using ANOVA followed by 
Dunnet‟s t test. P<0.05 were considered significant. 
 
 
 
Groups Treatment 
Group I Normal Control 
Group II Diabetic control- STZ (55 mg/kg ) 
Group III Diabetic control- Glibenclamide (5 mg/kg) 
Group IV Diabetic control- Elathy Urundai  100mg/kg  
Group V Diabetic control-   Elathy Urundai 200mg/kg  
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Anti-Dyslipidemic activity 
Triton WR 1339 induced Dyslipidemia for Elathy Urundai 
Experimental protocol 
Total number of groups   :  4 
Number of animals / group  :  6 
Sex     :  Both 
Strain     :  Wistar albino rats 
Body Weight    :  200 – 250 g 
Surfactant administration 
Surfactant    :  10% Triton WR – 1339 
Route of administration   :  Intravenously  
Vehicle     :  Saline 
Test drug administration 
Vehicle     :  2% CMC 
Route of administration   :  Oral 
Drug dose    :  Elathy Urundai - 200 mg/kg b.wt 
Procedure 
 Wistar rats weighing 200–350 g were starved for 18 hours and then injected 
intravenously with 10% Triton WR 1339 (isooctyl-polyoxyethylene phenol).  
Phase I: Serum cholesterol levels increase sharply 2–3 times after 24 hours. 
Phase II: The hypercholesterolemia decreases nearly to control levels within 
the next 24 hours.    
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 The test drug (Elathy Urundai)  employed or the solvent for the controls are 
administered simultaneously with the Triton injection or 22 hours thereafter. Serum 
cholesterol analyses are made 6, 24, and 48 hours after Triton injection.  
Mechanism 
 The mechanism of the Triton induced hypercholesterolemia in phase I was 
thought to be due to increased hepatic synthesis of cholesterol through the ability of 
Triton to interfere with the uptake of plasma lipids by the tissues. Drugs interfering 
with cholesterol biosynthesis were shown to be active in phase I, while drugs 
interfering with cholesterol excretion and metabolism were active in phase II
[63]
. 
Experimental design 
 The animals were divided into three groups with six animals in each group. 
Group I  →   Normal control administered with 2% CMC 
Group II  →   Dyslipidemic control received 10% Triton WR – 1339 
Group III  →   Standard administered with Lovastatin (10 mg/kg b.wt) and triton 
Group IV  →   Test drug Elathy Urundai - 100mg/kg b.wt. 
Group V  →   Test drug Elathy Urundai - 200mg/kg b.wt. 
 All the animals after 72 hours of triton injection (i.e., after inducing 
dyslipidemia) the respective treatment was continued for 7 days. 
Collection of blood 
 On the 8th day the blood was collected by retro orbital sinus puncture, under 
mild ether anesthesia. The collected samples were centrifuged for 10 minutes. Then 
serum samples were collected and it is used for various biochemical experiments. 
Then animals were sacrificed and collected the liver. 
Biochemical analysis 
 Total cholesterol 
 High-density lipoprotein 
 Low-density lipoprotein 
 Very low density lipoprotein 
 Triglycerides 
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Anti-Oxidant activity of Elathy Urundai (In-Vitro study) 
Free radical scavenging activity 
DPPH Assay (2, 2-diphenyl -1-picrylhydrazyl) 
 The radical scavenging activity of extracts was determined by using DPPH 
assay according to Chang et al [2001].The decrease in the absorption of the DPPH 
solution after the addition of an antioxidant was measured at 517 nm. Ascorbic acid 
(10mg/ml DMSO) was used.  
Principle 
 1, 1-diphenyl-2-picryl hydrazyl was a stable free radical with red colour which 
turns yellow when scavenged. The DPPH assay uses this character to show free 
radical scavenging activity. The scavenging reaction between (DPPH) and an 
antioxidant (H-A) can be written as, 
   DPPH + [H-A] →DPPH-H + (A) 
Antioxidants react with DPPH and reduce it to DPPH-H and as consequence 
the absorbance decreases. The degree of discoloration indicates the scavenging 
potential of the antioxidant compounds or extracts in terms of hydrogen donating 
ability
 [64]
. 
Reagent preparation 
0.1mm DPPH solution was prepared by dissolving 4mg of DPPH in 100ml of 
ethanol.  
Procedure 
 Different volumes (2.5µl - 40µl) of plant extracts were made up to a final 
volume of 40µl with DMSO and 2.96ml DPPH (0.1mM) solution was added. The 
reaction mixture incubated in dark condition at room temperature for 20 minutes. 
After 20 minutes, the absorbance of the mixture was read at 517nm. 3ml of DPPH 
was taken as control. 
Calculation 
                                 Control – test  
                            % inhibition =                               ˟ 100 
                                                          Control 
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                          5. RESULTS AND DISCUSSION 
 Many studies have been carried out to bring the efficacy and potency of the 
drug Elathy Urundai. The study includes literary collections, organoleptic character, 
physicochemical, instrumental analysis, toxicological study and pharmacological 
study. The drug Elathy Urundai has been selected for Anti-Diabetic activity in 
reference with the text “Sarabenthirar vaithiya muraigal”. 
 Literary collections about the drug from various text books were done. Siddha 
literatures related to the drug bring the evidence and importance of its utility in 
treating the diabetes. 
 Gunapadam review brings the effectiveness of the ingredients present in the 
drug for Anti-diabetic, Anti-dyslipidemic and Anti-oxidant properties. 
 Botanical aspect explains the identification, morphological description, 
microscopic character, macroscopic character, active principle and medicinal 
uses of the plants.  
 Siddha and modern aspect of disease explains about clinical features and 
complication of Diabetes mellitus and also explains adverse effect of drugs 
used in modern aspect.  
 Pharmaceutical review describes about the purification, preparation, 
administration of   Mathirai and explains about its self-life properties.  
 The pharmacological review explains about the methodology of Anti-Diabetic 
Activity and the drugs used. 
Standardization of the test drug 
 Standardization of the drug is more essential to derive the efficacy, potency of 
the drug by analyzing it by various studies. Following are the results of 
physicochemical. Physical characterization and estimation of basic and acidic radicals 
have been done and tabulated.  
 Toxicological results of the drug and pharmacological activity of the drug 
were derived. Its result has been tabulated and interpretation was made below. Thus it 
is to give a complete justification to bring the effectiveness of the trial drug Elathy 
Urundai. 
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Organoleptic character 
Table No.6. Physical characterization of Elathy Urundai 
 
 
Discussion  
 pH of Elathy Urundai is 4.41 It is acidic in nature[65]. The acidic medium is 
higher oral bioavailability and was likely to be the result of better solubility 
and lower clearance. So, the result concludes that the oral bioavailability of the 
drug is very high
 [66]
.  
 The amount of minerals and earthy materials present in the drug are 
represented by Total ash value. The value of Elathy Urundai.  is 5.68%, it 
determines the purity of the drug. 
S.no Parameter Results 
1 Colour Brown 
2 Odour Pleasant 
3 Taste Umami 
4 Consistency Hard 
5 Shape Spherical 
6 State of matter Solid 
7 pH 4.41 
8 Total ash 5.68% 
9 Water soluble Ash 2.47% 
10 Acid insoluble Ash 1.10% 
11 Solubility  
 I Distilled water Soluble 
 II Benzene Soluble 
 III Chloroform Soluble 
 IV Carbon tetra chloride Soluble 
 V Xylene Soluble 
 VI Petroleum ether Soluble 
12 Loss on Drying at 105
0
C 4.50% 
13 Disintegration time 16 min 
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 Water soluble ash represents easy facilitation of diffusion and osmosis 
mechanism. Here the value of Elathy Urundai is 2.47% will denote its 
diffusion capacity. 
 The amounts of siliceous matters in the drug are represented by acid insoluble 
ash value. The acid insoluble ash value of Elathy Urundai is 1.10%, which 
determines the superior quality of the Elathy Urundai. 
 The moisture content of the drug is determined by loss on drying. These will 
also indicate stability and shelf life of the drug. Here the percentage denotes 
the higher stability of the Elathy Urundai.  
 Elathy Urundai is formulated according to classical Siddha text, disintegration 
indicates the better solubility and absorbability of drug.  
Weight variation test 
           Table No.7. Uniformity weight variation test result of Elathy Urundai  
S.No. Weight of each 
Mathirai (mg) 
% of weight 
variation 
Maximum weight 
variation with in 
±7.5% 
Maximum weight 
variation with in 
±15.0% 
1 138 5.423% Yes Yes 
2 137 4.660% Yes Yes 
3 132 0.840% Yes Yes 
4 130 -0.687% Yes Yes 
5 139 6.187% Yes Yes 
6 135 3.132% Yes Yes 
7 126 -3.743% Yes Yes 
8 129 -1.451% Yes Yes 
9 125 -4.507% Yes Yes 
10 133 1.604% Yes Yes 
11 127 -2.979% Yes Yes 
12 128 -2.215% Yes Yes 
13 136 3.896% Yes Yes 
14 124 -5.271% Yes Yes 
15 129 -1.451% Yes Yes 
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S.No. Weight of each 
Mathirai (mg) 
% of weight 
variation 
Maximum weight 
variation with in 
±7.5% 
Maximum weight 
variation with in 
±15.0% 
16 131 0.076% Yes Yes 
17 135 3.132% Yes Yes 
18 120 -8.326% No Yes 
19 122 -6.799% Yes Yes 
20 126 -3.743% Yes Yes 
 Average : 130.95 mg 
 
Discussion 
 Average weight of the Mathirai was noted as 129.855g. Out of 20 tablets 
tested, 19 tab of them lies within ±7.5% weight variation (1 tab above the 
limit) and all 20 tab lies within ±15% weight variation.   
 According to the limits of weight test cited in the Indian pharmacopoeia, 
Elathy Urundai passed the Uniformity weight test.  
 The uniformity test resembles uniformal distribution of this tablet helps good 
absorption and distribution.  
Traditional test for pill 
  Character                                                                            Inference 
 Non sticky on rolling       + 
 No cracks over the surface after drying    + 
 Shall be rolled uniformly over the plane surface   +  
Phyto chemical analysis 
 Table No.8. Results of phyto chemical findings of Elathy Urundai 
 Phytochemicals Test used             Result 
Flavonoids  Shinoda test  Positive 
Tannins Gelatin test Positive  
Phenols Ferric chloride acetic 
acid test 
Positive 
Alkaloids  Mayer’s test Positive  
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Discussion 
Phytochemicals are natural bioactive compound found in plants and fibers 
which act as a defense system against diseases and more accurately, to protect against 
diseases. The phytochemical analysis reveals the presence of alkaloids, tannins, 
flavonoids, anthral glycosides, cardiac glycosides, saponins, phenols, proteins and 
carbohydrates.  
Flavonoids 
 It is the most important group of polyphenolic compounds in plants. 
 Flavonoids have potent Anti-Oxidant activity and it is its important 
function. 
 Oxidative stress plays a vital role in the pathogenesis of diabetes mellitus. 
 Flavonoids are potent water-soluble antioxidants and free radical 
scavengers which prevent oxidative cell damage and have strong 
anticancer activity
 [67]. 
Flavonoids can exert their Anti-Oxidant activity by 
scavenging the free radicals, by chelating metal ions or by inhibiting 
enzymatic systems responsible for free radical generation. 
 It also possesses anti-microbial activity which is confirmed by the various 
anti-microbial assays.  
Tannins 
 Reported to have anti-diabetic activity.  
 They restore the Anti-Oxidant status of the organs to almost normal levels. 
 Increases the cellular Anti-Oxidant enzymes. 
 Helps in healing of wounds and inflammation of mucous membrane. 
Phenols 
 Effective anti-hyperglycaemic agent. 
 They possess rich Anti-Oxidant property and protect body from oxidative 
stress. 
 Phenol groups are the essential part of many anti-oxidant compounds. 
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Alkaloids 
 Alkaloids possess antispasmodic, analgesic, bactericidal effects. 
 Alkaloids are the active principles producing many essential effects in 
protecting the body. 
 A synergistic effect of all these flavonoids, alkaloids, glycosides, tannins, 
phenols, increases the potency of the drug against Diabetes mellitus. 
TLC Photo documentation  : Elathy Urundai 
Stationary Phase - Silica Gel 60 F254 
Mobile Phase – Toluene: Ethyl acetate: Formic Acid (5:1.5:0.15 v/v/v) 
        
 λ = 254 nm  λ  = 366 nm  
 
λ  = 575 nm (Derivatized) 
 
Table No.9. Rf values  
Color Rf  value(s) Color Rf  value(s) Color Rf value(s) 
Grey 0.21 Green 0.10 Grey 0.08 
Grey 0.28 Red 0.15 Blue 0.22 
Grey 0.38 Green 0.22 Brown 0.30 
Grey 0.42 Red 0.24 Yellow 0.39 
Bright blue 0.48 Blue 0.26 Brown 0.51 
Grey 0.88 Red 0.30 Black 0.58 
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Color Rf  value(s) Color Rf  value(s) Color Rf value(s) 
  Red 0.35 Violet 0.69 
  Green 0.36 Black 0.90 
  Bright Green 0.47   
  Red 0.68   
  Red 0.79   
  Red 0.96   
 
 Under UV 254nm, it shows 6 major spots at Rf  0.21, 0.28, 0.38, 0.42, 0.48, 
0.52, 0.88 major compounds are found. 
 Under UV 366nm, it shows 12 major spots at Rf 0.10, 0.15, 0.22, 0.24, 
0.26, 0.30, 0.35, 0.36, 0.47, 0.68, 0.79, 0.96 major compounds are found. 
 Under UV 575nm, it shows 8 major spots at Rf 0.08, 0.22, 0.30, 0.39, 0.51, 
0.58, 0.69, 0.90 major compounds are found. 
3D Chromatogram of 254 nm: 
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HPTLC Cromatogram @ 254 nm:  
 
 
Table No.10. Peak Table @ 254 nm: 
    
 
Discussion  
 The quantitative analysis of compounds present in the EU has been performed 
by HPTLC. The method may be applied to identify the EU from other 
manufacturing process. It provides the identification of constituents, 
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determination of impurities and quantitative determination of active substance 
present in EU
[68]
. 
 The Rf value of the EU supports the better standardization of the drug. 
 The present study revealed that EU showed best results in Toluene: Ethyl 
Acetate (5:1.5) Solvent system. After scanning and visualizing the plates in 
absorbance mode at 254nm, 366nm and 575nm. Best results were shown at 
visible light range. 
 EU plate showed different colour phytoconstituents of chloroform extract of 
EU. The bands revealed presence of seven violets, four reds, two greens, one 
blue, one white and one yellow, bands showing the presence of alkaloids, 
glycosides, phenols, triterpenes, flavonoids and quinines. 
The results from HPTLC finger print scanned for extract of EU. There are 
thirteen polyvalent phytoconstituents and corresponding ascending order of Rf values 
start from -0.02 to 0.95 in which highest concentration of the phytoconstituents was 
found to be 32.94% and 19.34% with its corresponding Rf value found to be 0.12 and 
0.89 respectively. 
Bio chemical analysis 
Basic radicals 
Table No.11. Results for Basic radicals 
S.NO Parameter Observation Result 
1 Test for Potassium Yellow colour precipitate +ve 
2 Test For Magnesium White colour precipitate +ve 
3 Test For Sodium Yellow colour +ve 
4 Test For Zinc 
Formation of white   
precipate 
+ve 
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Interpretation 
 The basic radical test shows the presence of Potassium, Magnesium, Sodium, 
Zinc and absence of heavy metals. 
Potassium 
 The K+ inwardly rectifier channel (KIR) is one of the two sub-units of the 
pancreatic islet ATP-sensitive potassium channel complex (IKATP). It has a key role 
in glucose-stimulated insulin secretion and thus is a potential candidate for a genetic 
defect in Type II (non-insulin-dependent) diabetes mellitus [69]. 
Magnesium 
 Hypomagnesemia is a common feature in patients with type 2 diabetes. 
 Magnesium is the necessary cofactor for many enzymes that play a vital role 
in glucose metabolism. 
 Magnesium has a beneficial effect on insulin action and glucose   
metabolism
 [70]
. 
 Mg repletion may play a role in delaying the onset of Diabetes and 
potentially warding of its complications
 [71]
.  
Sodium 
 Recently sodium glucose cotransporter 2 reabsorbs most of the glucose 
filtered by the kidneys. Thereby, lowering the blood glucose levels and have 
been approved as new anti hyperglycemic drug [72].  
 A synergistic effect of all these Calcium, Iron, Potassium, Sodium, 
Phosphorus and Sulphur increases the potency of the drug against Diabetes 
mellitus. 
  Zinc 
 Zinc is concentrated in the islet cells and was related to the synthesis, 
storage and secretion of insulin. 
 It is essential in insulin action and carbohydrate metabolism. 
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 Zinc is the structural part of the key Anti-Oxidant enzymes such as 
superoxide dismutase. Therefore deficiency of zinc impairs their synthesis, 
leading to increased oxidative stress. 
 It improves the glycemic control and lipid parameter with probable 
movement in Anti-Oxidant status. 
 It has a beneficial effect on diabetic neuropathy and nephropathy. 
Acid radical 
Table No.12. Results for Acid radicals 
S.NO Parameter Observation Result 
1 Test for Chloride 
Formation of white 
precipitate 
Positive 
Interpretation 
The acidic radicals test shows the presence of Chloride. 
Chloride 
           The Chloride ions are responsible for buffering action and thus it maintains the 
equilibrium of the cell membrane. 
Microbial load 
Availability of bacterial and fungal load in Elathy Urundai 
 Table No.13. Bacterial and fungal dilutions 
         MICROBES      DILUTION         RESULT 
         BACTERIA            10
-4 
8 
         BACTERIA            10
-6 
6 
         FUNGI            10
-2 
3 
         FUNGI            10
-3 
2 
                        
 The contaminated toxins present in the drug will produce adverse effect, 
which develops unwanted diseases. They are unfit for humans
[73] . 
 Here, the contamination of Elathy Urundai  have been examine by bacterial 
and fungal load.  
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 Total bacterial load in 10-4 dilution is 8 and in 10-6 dilution is 6. 
 Total fungal load in 10-2 dilution is 3 and in 10-3 dilution is 2.  
 The load of bacterial and fungal are within the limits of WHO norms. 
Instrumental analysis 
                                               FTIR Spectrum analysis 
 Table No.14. FTIR Result of Elathy Urundai 
CHARACTERISTIC 
ABSORPTION(S)  (cm
-1
) 
FUNTIONAL GROUPS 
3308 N-H stretch      1º 2º amines ,amides 
2962 
 
O-H stretch     Carboxylic acids 
1657 -C=C-stretch   alkenes 
1541 N-O a symmetric stretch  nitro compounds   
1456 C-H bend   alkanes 
1384 C-H rock   alkanes 
1308 C-O stretch aromatic amines  
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495 
475 
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CHARACTERISTIC 
ABSORPTION(S)  (cm
-1
) 
FUNTIONAL GROUPS 
1170 C-H wag(-CH2X) alkyl halides 
1124 C-N stretch  aliphatic amines 
651 C-Br stretch  alkyl halides 
584 C-Br stretch  alkyl halides 
Interpretation 
 In FT-IR Spectra  analysis, this sample Elathy Urundai exhibits the peak value 
at 3308, 2962,1657,1541,1456,1384,1308,1170,1124,651,584, having N-
Hstretch, O-H stretch,-C=C-stretch, N-O a symmetric stretch, C-H-bend, C-H 
stretch, C-H wag(-CH2X), C-N stretch,C-Br stretch.  
 This indicates the presence of some organic functional groups such as 1, 2 
amines, amides, carboxylic acids, alkenes, nitro compound, alkanes, aromatic 
amines, alkyl halides, aliphatic amines, alkyl halides. The OH group has 
higher potential towards inhibitory activity against microorganisms.   
 Sometimes the presences of Phenols in medicinal plants possess highly Anti-
Oxidant property which enhances the drug effect against the disease
.
 For 
example, the phenolic compound of Hypericum perforatu. 
 
Scanning Electron Microscopy (SEM)      
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         Scanned electronmicroscope image of Elathy Urundai 
Discussion 
 In the above SEM studies of the drug Elathy Urundai showed objects 
of sizes ranging from 3µm to 20µm. The surface of the sample grains 
is uniformly arranged in agglomerates.  
 Size and surface of micro particles can be easily manipulated to 
achieve both passive and active drug targeting. 
 They control the release of drug during the transportation and at the 
site of localization, alters drug distribution in the body and subsequent 
clearance of the drug so as to achieve increased drug therapeutic 
efficacy thereby bio-availability and reduced side effects
 [74].\
 
XRD – X ray Diffraction Studies 
 
 
 
 
 
 
 
 
177nm 
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Interpretation 
           The structure, the size and shape of the particals are highly dependent on the 
route of synthesis and high lights the efficacy of the drug. The micro particles may 
enhance bio absorption of the drug. 
The major diffraction peakes are identified after XRD analysis EU concluded 
that range is 27-52nm associated with organic molecules probably  plays an important 
role in making it biocompatible and nontoxic at therapeutic doses. Other elements 
present in EU act as additional supplement and possibly helps in increase the efficacy 
of the formulation.    
 ICP-OES 
Table No.15. ICP-OES Result of Elathy Urundai 
S. no Elements Detected levels 
1. Aluminium BDL 
2. Arsenic BDL 
3. Cadmium BDL 
4. Copper BDL 
5. Mercury BDL 
6. Potassium 03.001 mg/L 
7. Sodium 54.300 mg/L 
8. Nickel BDL 
9. Lead BDL 
10. Phosphorus 101.311 mg/L 
         
      Discussion 
 
 The presence of Potassium (03.001 mg/l), Sodium (54.300mg/l), 
Phosphorous (101.311mg/l), is physiologically important.  
 In Elathy Urundai, the heavy metals like Aluminium, Arsenic, Cadmium, 
Copper, Mercury and Lead were below detectable level. This reveals the 
safety of the drug. 
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 From the above results, that the trial drug is safe as it contains heavy 
metals are observed within the permissible limits.  
 Hence the safety of the drug Elathy Urundai  is ensured. 
Potassium 
 The K+ inwardly rectifier channel (KIR) is one of the two sub-units of 
the pancreatic islet ATP-sensitive potassium channel complex 
(IKATP). 
 It has a key role in glucose-stimulated insulin secretion and thus is a 
potential candidate for a genetic defect in Type II (non-insulin-
dependent) diabetes mellitus. 
Sodium 
 Recently sodium glucose cotransporter 2 reabsorbs most of the glucose 
filtered by the kidneys. Thereby, lowering the blood glucose levels and 
have been approved as new anti hyperglycemic drug [58].  
 A synergistic effect of all these Calcium, Iron, Potassium, Sodium, 
Phosphorus and Sulphur increases the potency of the drug against 
Diabetes mellitus. 
Phosphorus 
 Phosphorus is needed for the growth, maintenance, and repair of all 
tissues and cells, and for the production of genetic building blocks, 
DNA and RNA.  
 Phosphorus also need to help balance and use other vitamins and 
minerals, including vitamin D, iodine, magnesium and zinc. 
 Phosphorous was associated with the lower risk of Diabetes mellitus.  
 A synergistic effect of all these Potassium, Sodium and Phosphorus 
increases the potency of the drug against Diabetes mellitus. 
 
 
 
RESULTS AND DISCUSSION 
 
ANTI DIABETIC ACTIVITY OF ELATHY  URUNDAI  Page 89 
 
TOXICOLOGY STUDIES 
Acute oral toxicity in rats– OECD 423 
 Wistar albino rat was treated with the test drug Elathy Urundai of single dose 
of 2000mg/kg in 2%CMC as suspention. This study was conducted as per the OECD 
guidelines. The result of acute toxicity of Elathy Urundai has been tabulated below. 
Table No.16. Observation in acute toxicity study 
SL Group 
CONTROL 
Observation SL Group 
TEST GROUP 
Observation 
1 Body weight Normal 1 Body weight 
 
Normally increased 
 2 
Assessments of 
posture 
Normal 2 Assessments of posture Normal 
3 
Signs of Convulsion 
Limb paralysis 
Normal 3 
Signs of Convulsion 
Limb paralysis 
Absence of sign (-) 
4 Body tone Normal 4 Body tone Normal 
5 Lacrimation Normal 5 Lacrimation Absence 
6 Salivation Normal 6 Salivation Absence 
7 Change in skin color 
No significant color 
change 
7 Change in skin color 
No significant color 
change 
8 Piloerection Normal 8 Piloerection Normal 
9 Defecation Normal 
 
9 Defecation Normal 
 
10 Sensitivity response Normal 10 Sensitivity response Normal 
11 Locomotion Normal 11 Locomotion Normal 
12 Muscle gripness Normal 12 Muscle gripness Normal 
13 Rearing Mild 13 Rearing Mild 
14 Urination Normal 14 Urination Normal 
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Table No.17. Dose finding experiment and its behavioral signs of toxicity for Elathy 
Urundai 
No Dose 
mg/kg 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 
1. Control + - - + - + - - - - - - - - - - - - - - 
2. 2000mg 
 
+ - - + - + - - - - - - - - - - - - - - 
1.Alertness 2.Aggressiveness 3. Pile erection 4. Grooming   5.Gripping   6. Touch 
Response  7. Decreased Motor Activity   8.Tremors 9 Convulsions 10. Muscle Spasm 
11. Catatonia 12.Musclerelaxant 13.Hypnosis 14.Analgesia15.Lacrimation 16. 
Exophthalmos 17.Diarrhoea   18. Writhing   19 Respiration   20.  Mortality 
Body weight  
                     Table No.18. Body weight of wistar albino rats in acute group exposed 
to Elathy Urundai  
 
 
    
 
 
N.S- Not Significant, **(p > 0.01),  *(p >0.05), n = 10 values are 
mean ± S.D(One way ANOVA followed by Dunnett’s test) 
             Table No.19. Water intake of wistar albino rats in acute group exposed to 
Elathy Urundai  
DOSE 
 
DAYS 
1 6 14 
CONTROL 61 ± 1.12 62±2.22 63.9±1.14 
HIGH DOSE 62.2±1.1 63±1.14       64.20±24 
P value (p)* NS NS NS 
                
N.S- Not Significant, **(p > 0.01),  *(p >0.05), n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test) 
DOSE 
 
DAYS 
1 7 14 
CONTROL 280.2±42.30  281.4 ± 64.12 282.6 ±26.18 
HIGH DOSE 280.4± 21.24 281 ± 3.64 281.4 ± 2 
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Table No.20.  Food  intake (gm/day) of Wistar albino rats in acute group exposed 
to Elathy Urundai 
DOSE 
 
DAYS 
1 7 14 
CONTROL 56.24±2.22 56.2±7.42 58.4±3.46 
HIGH DOSE 60.6±1.63 60.6±2.62 64.1±5.38 
Discussion 
In the acute toxicity study, the rats were treated with different concentration of 
Elathy Urundai from the range of 5mg/kg to 2000mg/kg which did not produce signs 
of toxicity, behavioral changes, and mortality in the test groups as compared to the 
controls when observed during 14 days of the acute toxicity experimental period. 
 These results showed that a single oral dose of the extract showed no 
mortality of these rats even under higher dosage levels indicating the high margin of 
safety of this extract.    
 In acute toxicity test the Elathy Urundai  was found to be non-toxic at the 
dose level of 2000mg/ kg body weight. 
Results of sub-acute oral toxicity 28-days repeated dose study in rats 
 Wistar albino rat was treated with the test drug Elathy Urundai for 28 days  
repeated dose of 100mg/kg and 200 mg/kg in 2% CMC as suspention. This study was 
conducted as per the OECD guidelines. The result of sub-acute toxicity of Elathy 
Urundai has been tabulated below. 
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Body weight 
Table No.21. Body weight of wistar albino rats in sub acute group exposed to 
Elathy Urundai 
 
NS- Not Significant, **(p > 0.01),*(p >0.05), n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test) 
Water Intake 
Table No.22. Water intake (ml/day) of  Wistar albino rats group exposed to Elathy 
Urundai 
 
DOSE 
 
DAYS 
1 6 14 21 28 
CONTROL 50.1 ± 4.32 50±4.12 50.2±1.10 50±1.12 50.4±1.12 
LOW DOSE 52.1±1.11 52.8±2.22 52.6±1.42 53.2±2.26 52.4±1.21 
MID DOSE 53.1±1.12 53.3±1.11 53.1±2.21 53.4±1.12 53.4±1.42 
HIGH DOSE 54.1±1.41 54.2±1.42 54.4±1.44 54.6±1.52 55.8±2.82 
 
N.S- Not Significant, **(p > 0.01),  *(p >0.05), n = 10 values are mean ± S.D (One 
way ANOVA followed by Dunnett’s test) 
 
DOSE 
 
DAYS 
1 7 14 21 28 
CONTROL 230.2±15.45  231.5 ± 25.15 231.5 ± 15.50 232.5± 15.16 232.4 ± 15.15 
LOW DOSE 230.2 ± 46.22 231.8 ± 32.22 231.6± 66.74 232 ± 62.18 234.8± 54.24 
MID DOSE 230.4± 04.24 232.3 ± 46.54 233.2 ± 68.12 234.2 ± 51.26 236.4 ± 54.10 
HIGH DOSE 230.6± 64.94 236.6 ± 50.42 249.4 ± 12.24 251 ± 14.38 253 ± 54.61 
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Food Intake 
Table No.23. Food intake (gm/day) of Wistar albino rats group exposed to Elathy 
Urundai 
DOSE 
 
DAYS 
2 7 23 22 28 
CONTROL 30±5.14 31.2±2.12 31.3±2.18 31.2±1.14 32±2.12 
LOW DOSE 30.2±1.14 31.3±1.31 31.1±1.21 31.5±1.32 31.5±1.62 
MID DOSE 32.1±2.22 32.2±3.40 32.2±2.24 32.2±2.16 33.2±1.24 
HIGH DOSE 33.1±1.12 33.1±1.14 33.6±2.26 34.2±1.10 34.6±3.42 
    
 N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D (One 
way ANOVA followed by Dunnett’s test. 
 
Table No.24.  Haematological parameters of Wistar albino rats group exposed to Elathy 
Urundai 
Category Control Low dose Mid dose High dose 
Haemoglobin(g/dl) 16.7±0.71 16.60±0.24 16.5±0.23 16.82±0.16 
Total WBC (×10
3   
l) 10.81±0.32 10.64±0.21 10.54±0.42 9.60±1.12 
Neutrophils (%) 31.12±0.01 31.02±0.12 32.11±1.22 33.02±6.21 
lymphocyte (%) 72.12±1.24 72.12±1.32 73.10±2.34 73.20±2.44 
Monocyte (%) 0.9±0.02 0.9±0.01 0.9±0.04 0.9±0.03 
Eosinophil (%) 0.5±0.03 0.5±0.04 0.5±0.05 0.5±0.08 
Platelets cells10
3
/µl 680.17±3.13 682.41±4.12 682.13±2.02 684.10±2.34 
Total RBC 10
6
/ µl 8.42±0.12 8.46±0.53 8.49±0.44 8.74±0.46 
PCV% 42.12±0.2 42.62±1.02 43±1.20 44.40±2.10 
MCHC g/Dl 34.5±1.20 34.2±1.10 34.8±1.70 34.33±1.30 
MCV fL(µm
3
) 58.2±4.02 59.2±1.10 58.9±1.40 58.8±1.20 
            
            N.S- Not Significant, **(p > 0.01), *(p >0.05), n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test) 
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Table No.25. Biochemical Parameters of of Wistar albino rats group exposed to 
Elathy Urundai 
BIOCHEMICAL 
PARAMETERS 
CONTROL LOW DOSE MID DOSE HIGH DOSE 
GLUCOSE (R) (mg/dl) 125.11±3.2 125.12±2.10 126.10±13.08 128.12±4.2 
T.CHOLESTEROL(mg/dl) 120.16±1.20 120.25±1.30 122.60±1.18 123.24±1.30 
TRIGLY(mg/dl) 54.16±1.52 54.12±1.42 56.15±1.23 56.16±1.23 
LDL 72.4±2.14 72.12±2.54 73.10±1.32   73.24±10.20 
VLDL 11.2±1.30 11.20±2.21 11.22±1.24 11.14±12.14 
HDL 27.14±6.12 27.42±2.30 28.16±2.60 28.17±2.14 
Ratio 1(T.CHO/HDL) 3.41±1.16 3.42±1.40 3.74±1.04 3.64±2.03 
Ratio 2(LDL/HDL) 
 
1.92±1.14 1.91±1.12 1.71±2.20 1.96±08.02 
Albumin (g/dL) 5.43±0.16 5.50±0.52 5.04±9.30 5.42±9.48 
  
NS- Not Significant, **(p > 0.01), * (p >0.05), n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test) 
 Table No.26. Renal function test of of Wistar albino rats group exposed to 
Elathy Urundai   
PARAMETERS CONTROL LOW DOSE MID DOSE HIGH DOSE 
UREA (mg/dl) 26.70±0.19 26.50±0.26 27.16±1.28 27.68±1.24 
CREATININE(mg/dl) 0.22±0.02 0.21±0.04 0.22±0.05 0.24±0.07 
BUN(mg/dL) 17.1±0.01 17.10±0.64 17.6±0.52 17.86±1.02 
URIC ACID(mg/dl) 6.04±0.34 6.06±0.51 6.6±0.15 6.42±0.20 
 
      NS- Not Significant, **(p > 0.01), * (p >0.05) , n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test) 
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Table No.27. Liver Function Test of of Wistar albino rats group exposed to 
Elathy Urundai 
PARAMETERS CONTROL LOW DOSE MID DOSE HIGH DOSE 
T BILIRUBIN(mg/dl). 0.07±0.01 0.07±0.02 0.07±0.01 0.07±0.03 
SGOT/AST(U/L) 81.14±1.63 81.31±0.02 82.01±1.24 82.64±1.63 
SGPT/ALT(U/L) 78.12±1.08 78.21±1.24 78.14±1.26 77.68±0.01 
ALP(U/L) 119.21±3.16 119±32.10 119±12.14 120.03±8.32 
T.PROTEIN(g/dL) 6.2.10±0.04 6.2±0.11 6.2±0.10 6.4±0.46 
 
NS- Not Significant, **(p > 0.01), * (p >0.05), n = 10 values are mean ± S.D 
(One way ANOVA followed by Dunnett’s test. 
 
DISCUSSION 
Body weight 
The result of the body weight of rats exposed to control and the trial drug of 
different dose groups exhibited overall mild weight gain throughout the dosing period 
of 28 days. The quantity of food taken by the animals from different dose groups and 
the control is comparably normal. 
Water intake 
There is no significant change in water intake by the animal during the period 
of study. 
Food intake 
            The weight increase of the animals showed that the intake of food by the 
animals was good during the period of 28 days study. 
Haematological investigation 
                       There was no significant changes were observed in hemoglobin (Hb), 
red blood cell (RBC), white blood cell (WBC), packed cell volume (PCV), 
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Erythrocyte sedimentation rate (ESR) in all the treated groups as compared to 
respective control groups. The increase and decrease in the values obtained were all 
within the normal biological and laboratory limits. 
Biochemical investigation 
             No significant changes were observed in the values of different parameters 
studied when compared with controls and values obtained were within normal 
biological and laboratory limits. 
Renal function test 
 The renal function test of the animals shows the normal limits thus the trial 
drug was safe and not produce any nephro toxicity, thus it suggests that the trial drug 
was safe for long term administration. 
Liver function test 
 The total bilirubin, bilirubin direct and bilirubin indirect showed that normal 
range.  
Thus the liver function test of Elathy Urundai shows normal in this 28 day 
repeated oral toxicity. 
Discussion 
 From histopathological examinations, the slides of animal’s organ did 
not reveal abnormalities. 
 From the acute and sub-acute toxicity studies the drug produced some 
significant changes .But the values were found within normal limits. 
So the drug Elathy Urundai was nontoxic and safe. 
 Thus the safety of the drug is revealed so that it can be administered 
for long time without any side effects. 
 
 
 
RESULTS AND DISCUSSION 
 
ANTI DIABETIC ACTIVITY OF ELATHY  URUNDAI  Page 97 
 
PHARMACOLOGY STUDIES 
Anti-Diabetic activity  
Blood glucose level 
Table No.28. Effect of Elathy Urundai on Blood glucose level in Streptozotocin 
induced diabetic rats 
Group   Blood glucose (mg/dl) 
Day-0 Day-7 Day-14 Day-21 Day-28 
Normal 
Control 
89.40±1.30 87.53±1.38 92.75±2.86 85.13±2.46 94.70±2.18 
Diabetic 
Control 
106.22±1.42 240.9±1.62 275.3±1.46 287.8±1.30 295.4±1.21 
Diabetic rats + 
Glibenclamide 
103.5±1.46 161.0±1.34** 152.05±1.3** 124.2±1.43*** 112.3±1.46*** 
Diabetic rats + 
EU 100mg/kg 
100.13±1.22 200.12±1.05 186.24±2.17 167.81±1.20** 142.5±1.44** 
Diabetic rats + 
EU 200mg/dl 
94.23±1.38 189.8±1.34* 168.04±1.28** 134.03±1.70*** 120.8±1.83*** 
   Values are expressed as mean ±SEM (Dunnett’s test). *P˂0.05 – Significant,       
**P˂0.01 – Highly Significant, ***P˂0.001 Extremely Significan 
 
 
 
 
 
 
\  Chart.1. Anti Diabetic activity of Elathy Urundai 
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Body weight in Streptozotocin induced diabetic rats 
 Table No.29. Effect of Elathy Urundai on body weight in Streptozotocin induced 
diabetic rats 
Group 
No. 
Treatment  Body weight (g) on post induction days 
Initial 5
th
 day 15
th
 day 20
th
 day 
I Normal control 166.25±2.52 168.89±3.21 169.47±2.58 170.45±2.45 
II Diabetic Control 164.49±2.78 162.80± 3.34 135.80±2.10++ 124.30±2.33++ 
III Diabetic rats + 
Glibenclamide 
161.40±3.26 164.10 ± 2.77 169.8±3.26 177.30 ± 2.37** 
IV Diabetic rats + 
EU 100mg/kg 
166.40±5.78 166.60 ± 3.23 168.80 ± 4.86 172.40± 5.89** 
V Diabetic rats + 
EU 200mg/dl 
165.34±6.12 167.42±3.86 168.97±4.99 174.68±6.08** 
 Values are expressed as mean ±SEM (Dunnett’s test). *P˂0.05 – Significant, 
   **P˂0.01 – Highly Significant, ***P˂0.001 Extremely Significant. 
 
 
 
 
 
 
 
 
  Chart.2.Body weight in Diabetes induced rats 
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Interpretation 
Anti Diabetic activity 
 The Anti-Diabetic Activity of the test drug Elathy Urundai has been estimated 
in the streptozotocin induced diabetes in Wistar albino rat. 
 Administration of the streptozotocin effectively induced diabetes mellitus in 
the animal model which is known by the increased glucose level. 
 STZ, slightly cytotoxic agent of pancreatic beta cells, selectively destroys the 
pancreatic insulin secreting beta cells, thus leaving less active cells and resulting in 
diabetes mellitus. Thus it is widely used to induce diabetes in animal models. It also 
interferes with cellular metabolic oxidative mechanisms
 [75]
. 
 Oral administration of the test drug Elathy Urundai taken in the dose of 
200mg/kg showed significant decrease in the sugar level.  
 The possible mechanism by which the test drug Elathy Urundai brings about a 
decrease in the blood sugar may be by potentiation of the insulin effect of plasma by 
increasing either the pancreatic secretion of insulin from β-cells of the islets of 
Langerhans or its release.  
          Elathy Urundai a Siddha herbal formulation used in the treatment of diabetes 
shows significant reduction in the sugar level which was studied by inducing diabetes 
in the animal model Wistar albino rat by streptozotocin.  
Body weight changes 
 Body weight of the animal models in this study was also monitored. There is 
decrease in the body weight of the animal treated with the control. Whereas the 
animal treated with Elathy Urundai shows a significant improvement in the body 
weight. Thus the trial drug not only reduced the sugar level but also maintains the 
body weight in Diabetes Mellitus.  
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Anti-Dyslipidemic activity 
Table No.30. Effect of Elathy Urundai  on lipid profile of Triton induced Dyslipidemia in 
rats 
 
Gro
up 
No. 
 
Lipid 
Parameters 
     
HDL 
Mg/dl 
Total 
Cholesterol 
Mg/dl 
LDL 
Mg/dl 
VLDL 
Mg/dl 
TGL 
Mg/dl 
I Normal control 72.80±1.20 57.43±2.2 19.74±0.60 65.02±1.88 33.23±1.25 
II Triton Control 172.81±7.43 127.80±0.90 81.50±3.55 127.50±1.70 28.30±0.97 
III Dyslipidemic+ 
Levostatin 
63.13±7.3** 50.40± 6.10** 41.50±4.08** 57.20 ± 2.04* 69.90±1.59* 
IV Dyslipidemic + 
EU100mg/kg 
72.90±8.4* 52.10±3.20** 51.25±4.86* 56.25±2.40* 73.80±2.49 
V Dyslipidemic + 
EU 200mg/kg 
73.50±1.03* 53.28 ± 3.70* 52.67 ± 3.26* 58.74±2.64* 71.21±2.45* 
 Values are expressed as mean ±SEM (Dunnett’s test). *P˂0.05 – Significant, 
      **P˂0.01 – Highly Significant, ***P˂0.001 Extremely Significant. 
 
 
 
 
 
 
 
Chart 3:- Anti Dyspipidemic activity 
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Interpretation 
Anti-hyperlipidemic activity of the test drug Elathy Urundai was conducted by 
Triton Wr 1339 induced hyperlipidemia in animal model Wistar albino rats. The 
results were tabulated above.  
The test drug Elathy Urundai of 200mg/kg b.wt showed significant changes in 
the lipid level. There is a significant decrease in the level of LDL, VLDL, TGL. There 
is a significant increase in the HDL also noted.  
The standard drug also showed the significant decrease in the LDL, VLDL, 
TG. But there is no significant increase in the HDL. 
Diabetes mellitus (DM) is a group of metabolic diseases characterized by 
hyperglycemia, hypertriglyceridaemia and hypercholesterolaemia, resulting from 
defects in insulin secretion or action or both
 [76]
. 
In diabetes mellitus along with hyperglycemia there is hyperlipidemia always 
accompanied representing risk factor for coronary heart disease and other 
complications.  
Deficiency in insulin or insulin resistance may be responsible for 
hyperlipidemia. Insulin has a inhibiting action on the enzymes involved in 
biosynthesis of cholesterol.  
Therefore deficiency of insulin results in the increase in level of LDL, VLDL, 
TG, cholesterol and decrease in HDL.  
Hyperlipidemia produces further vascular complications and increases the 
severity of diabetes
 [77]
.  
The drug showed significant decrease in the LDL which is almost equal to the 
standard and marked increase in the HDL than the standard drug.  
Hence this anti-hyperlipidemic activity supports the anti-diabetic activity of 
the drug Elathy Urundai in giving an effective treatment of diabetes as a whole. 
 
 
 
 
RESULTS AND DISCUSSION 
 
ANTI DIABETIC ACTIVITY OF ELATHY  URUNDAI  Page 102 
 
Anti-oxidant activity 
                       Table No.31. Effect on Oxidative Stress by Elathy Urundai 
Sample 
concentration 
(µg/ml) 
Absorbance 
  
Percentage of 
Inhibition 
Drug Standard Drug Standard 
Control 0.5271 0.312 
 
- - 
1.25 0.3873 0.278 26.2103 40.89 
2.50 0.3585 0.202 33.2492 51.25 
5 0.3365 0.084 60.1038 74.07 
10 0.2901 0.052 71.2592 83.33 
20 0.2611 0.034 76.5702 89.62 
          
         
 
                             Chart.4.  Anti Oxidant activity 
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Interpretation 
 Anti-Oxidant study of the trial drug Elathy Urundai was conducted and the 
result has been given in the above table. The trial drug possesses significant Anti-
Oxidant property. 
 Oxidative stress is one of the major pathophysiology of the disease. Oxidative 
stress is associated with the increased production of reactive oxygen species and 
impaired antioxidant defense systems, which cause lipid peroxidation, alteration in 
antioxidant enzymes and impaired glutathione metabolism
 [78]. 
 In diabetes mellitus tissue damage is brought about mainly by the oxidative 
stress. There are certain enzymes involved in the Anti-Oxidant mechanism protecting 
the body from damage. The study shows the amount of the anti-oxidant enzymes 
increased significantly after the administration of the trial drug thus revealing its Anti-
Oxidant property. 
 Hence the test drug Elathy Urundai   possesses rich Anti-Oxidant property. 
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6. CONCLUSION 
 The drug Elathy Urundai was selected to validate the safety and its efficacy 
for Diabetes mellitus in animal model (Wistar albino rats). 
 The ingredients of the drug was identified and authenticated by Gunapadam 
experts. The drug was prepared as per classical Siddha literary procedure and 
subjected to various studies to reveal the potency and efficacy of the drug. 
 The Organoleptic character and physico chemical studies were made to 
standardization of the drug Elathy Urundai. From the above studies, the Elathy 
Urundai was standardized as per AYUSH guidelines. 
 The analysis of biochemical, instrumental was made to know the presence of 
active ingredients in the drug which is responsible for its activity. 
 Here, the biochemical analysis showed the presence of Potassium,Magnesium, 
Sodium,Zinc by its synergistic effect, the drug as activity against the disease. 
 In instrumental analysis, FTIR showed the peak values represents the 
functional groups responsible for its activity. SEM picture explained the particle size 
of the drug. In ICP-OES described about the absence of heavy metals and its 
permissible limits which showed the safety of the drug. 
 Toxicity studies revealed about the acute and sub-acute toxicity effect of the 
Elathy Urundai in rat models. The drug showed no toxicity and mortality in both 
acute and sub-acute toxicity. According to OECD guidelines, the haematological, 
biochemical parameters were investigated. There were no significant changes in the 
functional behaviour and in the normal values. Thus, it was established the safety of 
the drug administrated when for long time. 
 Pharmacological studies were done on the rat model for Anti diabetic, Anti- 
Dyslipidemic activity and In vitro study for Anti- oxidant activity. 
 In Diabetes the main pathophysiology is increased oxidative stress which 
results in the tissue damage and it is the main reason for other complications. The 
anti-oxidant property of this drug is mainly due to the presence of phytochemicals 
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(flavonoids, phenols, etc.,) and other active ingredients which involve in scavenging 
the free radicals and prevents tissue damage and other complications. 
 In Anti diabetic activity, there was significant decreased blood glucose level 
and slightly increased body weight in the Streptozotocin induced Wistar albino rats. 
 In Diabetes, hyperglycemia is always accompanied with the dyslipidemia. 
Deficiency of insulin results in the increase in level of LDL, VLDL, TGL, cholesterol 
and decrease in HDL. Dyslipidemia produces further vascular complications and 
increases the severity of Diabetes. The drug showed significant decrease in the LDL 
and marked increase in the HDL than the standard drug. 
 In Anti dyslipidemic activity, showed significant decreased LDL, VLDL, 
TGL, TC levels and marked increased HDL level in the triton WR-1339 induced 
dyslipidemic in Wistar albino rat models. 
 In Anti oxidant activity, there was significant effect of drug when compare to 
standard in DPPH assay. 
 Thus by surviving all the above factors, it is concluded that the drug Elathy 
Urundai is safe and potent drug with Anti diabetic and Anti-dyslipidemic activity 
with rich Anti-oxidant activity. This will support the treatment and management of 
diabetes and its complications. In treating, the disease with this drug it has a 
synergistic effect of controls blood sugar level, lipid profile and also reduces the 
oxidative stress and gives a complete treatment for diabetes and its complication as a 
whole.     
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     8. SUMMARY 
 From the Siddha literature “Sarabenthirar Vaithiya Muraigal” the drug 
Elathy Urundai was selected for its Anti-diabetic, Anti-dyslipidemic and Anti-
oxidant activities. 
 In this dissertation, Introduction explained about the disease diabetes in 
Modern aspect, prevalence of Diabetes, mortality and morbidity rate, about the 
Siddha concept, the disease diabetes in Siddha and role of the drug in treating 
diabetes. 
 The drug was prepared as per classical Siddha literature, the ingredients were 
identified and authenticated by Gunapadam experts. 
 In review of literature, many studies were carried out about the botanical 
aspect and Gunapadam aspect of the drugs. Pharmaceutical review enclosed 
about the preparation of drug and the pharmacological review established the 
methodologies. 
 The drug was subjected to various analysis such as physico chemical, 
biochemical and also instrumental analysis which provided the active 
ingredients present in the drug. 
 Toxicological study was made according to OECD guidelines showed the 
study of the drug. 
 Pharmacological studies were done to reveal the Anti-diabetic, Anti-
dyslipidemic activity in animal models and Anti-oxidant activity of Elathy 
Urundai in DPPH assay. 
 Results and discussion gave justifications to prove the potency of the drug. 
 Conclusion explained the synergistic effect of all active ingredients and 
activities that supports the study. 
 Thus, the herbal formulation Elathy Urundai which is validated for its safety 
and efficacy for treating Diabetes mellitus, would be a great drug of choice. 
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7. FUTURE SCOPE 
 The drug Elathy Urundai has its own potency in treating Diabetes mellitus in 
animal model which has been established in this study.  
 However, the mechanism of action by which Elathy Urundai produced its 
effect on decreasing the blood sugar level in experimental animals need to be 
evaluated in a scientific manner using specific experimental animal models and also 
multi-center clinical trials are required to understand the exact molecular mechanisms 
of action. So it could be used worldwide in treatment of Diabetes mellitus. 
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